Abstract
Position statement: The International Society of Sports Nutrition (ISSN) provides an objective and critical review of the mechanisms and use of probiotic supplementation to optimize the health, performance, and recovery of athletes. Based on the current available literature, the conclusions of the ISSN are as follows:
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host (FAO/WHO).
Probiotic administration has been linked to a multitude of health benefits, with gut and immune health being the most researched applications.
Despite the existence of shared, core mechanisms for probiotic function, health benefits of probiotics are strain- and dose-dependent.
Athletes have varying gut microbiota compositions that appear to reflect the activity level of the host in comparison to sedentary people, with the differences linked primarily to the volume of exercise and amount of protein consumption. Whether differences in gut microbiota composition affect probiotic efficacy is unknown.
The main function of the gut is to digest food and absorb nutrients. In athletic populations, certain probiotics strains can increase absorption of key nutrients such as amino acids from protein, and affect the pharmacology and physiological properties of multiple food components.
Immune depression in athletes worsens with excessive training load, psychological stress, disturbed sleep, and environmental extremes, all of which can contribute to an increased risk of respiratory tract infections. In certain situations, including exposure to crowds, foreign travel and poor hygiene at home, and training or competition venues, athletes’ exposure to pathogens may be elevated leading to increased rates of infections. Approximately 70% of the immune system is located in the gut and probiotic supplementation has been shown to promote a healthy immune response. In an athletic population, specific probiotic strains can reduce the number of episodes, severity and duration of upper respiratory tract infections.
Intense, prolonged exercise, especially in the heat, has been shown to increase gut permeability which potentially can result in systemic toxemia. Specific probiotic strains can improve the integrity of the gut-barrier function in athletes.
Administration of selected anti-inflammatory probiotic strains have been linked to improved recovery from muscle-damaging exercise.
The minimal effective dose and method of administration (potency per serving, single vs. split dose, delivery form) of a specific probiotic strain depends on validation studies for this particular strain. Products that contain probiotics must include the genus, species, and strain of each live microorganism on its label as well as the total estimated quantity of each probiotic strain at the end of the product’s shelf life, as measured by colony forming units (CFU) or live cells.
Preclinical and early human research has shown potential probiotic benefits relevant to an athletic population that include improved body composition and lean body mass, normalizing age-related declines in testosterone levels, reductions in cortisol levels indicating improved responses to a physical or mental stressor, reduction of exercise-induced lactate, and increased neurotransmitter synthesis, cognition and mood. However, these potential benefits require validation in more rigorous human studies and in an athletic population.
This position stand is dedicated to the late Dr. Mike Greenwood who made significant contributions to the development of the ISSN and JISSN.
This position stand has been adopted by the Austrian Society of Sports Nutrition (Österreichische Gesellschaft für Sporternährung (ÖGSE)).
Submitted to the ISSN Research Committee for consideration as a Position Stand of the Society
October 31, 2019
Introduction
The term probiotic is derived from the Latin preposition “pro,” which means “for” and the Greek word “biotic” meaning “life”. Probiotics are widely considered to be health-promoting microorganisms. As outlined in Table and as defined by the World Gastroenterology Organization (WGO), various ingredients can function in probiotic, prebiotic, and symbiotic roles. The Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) defines probiotics as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” [Citation1]. Additionally, the International Olympic Committee (IOC) has stated that, “Probiotics are live micro-organisms that when administered orally for several weeks can increase the numbers of beneficial bacteria in the gut. These have been associated with a range of potential benefits to gut health, as well as modulation of immune function” [Citation5]. Unique in comparison to other dietary supplements, probiotic preparations contain live, viable, defined microorganisms in sufficient numbers to provide beneficial health effects [Citation6]. Table provides an overview of common definitions and classifications related to probiotic research.
The probiotic principle dates back to over 100 years ago. In 1908, Elie Metchnikoff [Citation7] suggested that it would be possible to modify the microbiota in our bodies and replace harmful microbes with useful microbes. Reported health benefits of probiotics include modulation of the immune response, maintenance of the intestinal barrier, antagonism of pathogen adhesion to host tissue, and production of different metabolites such as vitamins, short-chain fatty acids (SCFAs), and molecules that act as neurotransmitters involved in gut–brain axis communication [Citation8]. In the last several decades, research in the area of probiotics has progressed considerably and significant advances have been made in the selection and characterization of specific probiotic cultures. A growing number of dietary supplements containing probiotics are commercially available worldwide, and the number of products being marketed to improve the health and performance of athletes continues to increase substantially. To appropriately describe a probiotic, the genus, species, and strain of each live microorganism (see Table ) must be detailed on a product label. Additionally, the product label should include the total estimated quantity of each probiotic strain at the end of the product’s shelf life, as measured by colony forming units (CFU) or live cells. Moreover, only a 70% DNA-DNA reassociation is needed for strains to be regarded as the same species [Citation9]. The difference between a Homo sapiens and its most closely related species, the chimpanzee (Pan troglodytes) is 98.4%. Reassociation rates of humans with other primates like Gorilla (97.7%), Orangutan (96.5%), Siamang gibbon (95.5%), and the Hamadras baboon (92.7%) are also relatively high. Further, Lemur (78%) are still within the range for probiotics to be considered the same species (see Fig. ). Analyzing potential health benefits of probiotics must occur on a strain level, and consumption of probiotic products only disclosing genus and species, but not the strain, on the label should be discouraged.
Probiotics are available commercially in capsule or tablet forms, as powder sachets, in the form of liquids and in specific foods such as yogurt and nutrition bars. While fermented foods, such as sauerkraut or kimchi, contain live microbes, they are currently not classified as probiotics, as those products have not been sufficiently studied for their health benefit as stipulated by the definition of probiotics. Stability concerns during manufacture and shelf-life limit food and supplement delivery forms. Probiotics exhibit strain-specific differences in their ability to colonize the gastrointestinal (GI) tract, clinical efficacy, and the type and magnitude of benefits to health in a range of different population cohorts [Citation10]. The effects of probiotics in athletes have been less described in comparison to animal studies and human clinical conditions in the general population. However, the body of probiotic research in recreational and competitive athletes is expanding, including investigations in GI health, exercise performance, recovery, physical fatigue, immunity, and body composition.
Role of diet and exercise on an athlete’s gut microbiome
Numerous factors such as age, genetics, drug use, stress, smoking, and especially diet can all affect the gut microbiome, influencing a complex ecosystem that is highly dynamic and individual [Citation11–Citation14]. In relation, physical activity has been an area of growing interest in gut microbiome research and appears to promote a health-associated microbiota. In the context of athletes, the present body of literature suggests their microbiota has several key differences in comparison to other populations, likely driven, in part, by exercise and diet. Indeed, several observational studies have investigated the difference in the composition of the gut microbiota between those who are highly physically active (including athletes) and a range of other populations. Reported results include that a higher abundance of health-promoting bacterial species [Citation15–Citation17], increased microbiome diversity [Citation16, Citation18], and greater relative increases in metabolic pathways (e.g. amino acid and antibiotic biosynthesis and carbohydrate metabolism) and fecal metabolites (e.g. microbial produced SCFAs; acetate, propionate, and butyrate) are associated with enhanced fitness [Citation17, Citation19].
The current evidence supports the role of exercise as an important behavioral factor that can affect qualitative and quantitative changes in the gut microbial composition with benefit to the host. Exercise appears to be able to enrich microbiota diversity [Citation20–Citation25], increase the Bacteroidetes-Firmicutes ratio [Citation23], stimulate the proliferation of bacteria which can modulate mucosal immunity [Citation26], improve barrier functions [Citation27], and stimulate bacteria capable of producing substances that protect against GI disorders [Citation28, Citation29]. Recent research provides further evidence for a role of exercise in shaping the microbiome, with elite runners having a greater abundance of Veillonella that appears to confer a metabolic advantage for endurance exercise by converting exercise-induced lactate to propionate. Pre-clinical studies with Veillonella show a 13% increase in endurance performance [Citation30]. It is likely that the diverse, metabolically favorable intestinal microbiome evident in the elite athlete is the cumulative manifestation of many years of high nutrient intake and high degrees of physical activity and training throughout youth, adolescence and during adult participation in professional sports [Citation31].
In researching the human gut microbiota, it is difficult to examine exercise and diet separately as this relationship is compounded by changes in dietary intakes that often are associated with physical activity (e.g., increased protein intake in resistance trained athletes or carbohydrate intake in endurance athletes and increased total energy and nutrient intake in general). Furthermore, comparing the microbiota of non-athletes to athletes and ascribing any observed differences to exercise alone is not advisable. Athletes generally consume a diet that differs from the general population that has implications for the composition of the gut microbiome.
Diet is an established modulator of gut microbiota composition, with significant change reported within 24 h of a dietary modification [Citation32]. Various food components, dietary patterns, and nutrients all have the potential to alter considerably the growth of different gut microbial populations. Partitioning of individuals into enterotypes appears to be driven by whether their primary dietary patterns include high complex carbohydrate (Prevotella) or high fat/protein (Bacteroides) consumption [Citation33]. Protein intake appears to be a strong modulator of the microbiota [Citation20, Citation32, Citation34], with whey protein showing some potential benefits that need further study in humans [Citation31, Citation35]. Carbohydrates are well known for their profound effect on the gut microbiota, with increased intake of dietary fiber associated with microbial richness and/or diversity [Citation36, Citation37]. In athletes, higher intakes of carbohydrates and dietary fiber appear to be associated with increased abundance of Prevotella [Citation17, Citation38]. The specific effects of fat on the gut microbiota is difficult to isolate, however, the types of fats consumed appear to be important [Citation39]. Increased fat intake may promote higher concentrations of bile-tolerant bacteria (presumably because an extremely high fat intake is known to increase bile acid secretion) [Citation32]. Further research is needed to determine the synthesis kinetics and clinical consequence of bile acids and their by-products during increased nutritional intake and metabolic demands during exercise.
Based on the current body of evidence, the athlete gut microbiome may possess a functional capacity that is primed for tissue repair and a greater ability to harness energy from the diet with increased capacity for carbohydrate, cell structure, and nucleotide biosynthesis [Citation19]. This assertion reflects the significant energy demands and tissue adaptation that occurs during intense exercise and elite sport. It appears that being physically active is another important factor in the relationship between the microbiota and host metabolism. Intervention-based studies to delineate this relationship will be important and may provide further insights into optimal therapies to influence the gut microbiota, and its relationship with health and disease as well as athletic performance. Fig. illustrates that an athlete’s gut microbiota is different from a sedentary individual with increased diversity and greater abundance of health promoting bacterial species linked to exercise and increased protein intake.
Benefits of probiotic supplementation in athletes
Strenuous and prolonged exercise places stress on the GI tract that increases the likelihood of multiple symptoms associated with a disturbed gut microbiota and decreased performance [Citation40], including abdominal cramping, acid reflux (heartburn), nausea, vomiting, diarrhea, and permeability of the gut that may precipitate systemic endotoxemia [Citation41]. As a major gateway for pathogen entry, the GI tract is heavily protected by the immune system. Modulation of the immune system to increase defenses against upper respiratory tract infection (URTI) is the potential benefit of probiotics for athletes that has been most extensively researched [Citation40]. The microbiome may also have indirect functional influence on various indices of exercise performance and recovery [Citation42–Citation46]. Therefore, probiotics as functional modulators of the microbiome can potentially promote health, exercise adaptation, and performance in athletes.
Probiotics may regulate the mucosal immune response [Citation47], improve the activity of macrophages [Citation48] and modulate the expression of the genes associated with macrophage activity. Probiotics may also interact with Toll-like receptors (TLRs) and downregulate the expression of nuclear factor (NF)-κB and pro-inflammatory cytokines [Citation49, Citation50]. Additionally, levels of anti-inflammatory cytokines and immunoglobulins, immune cell proliferation, and production of pro-inflammatory cytokines by T cells may be modulated following probiotic supplementation [Citation51, Citation52]. However, it is often difficult to study athletes during training and competition, and a wide range of interactions between diet, physical activity and other lifestyle stresses needs to be considered. Understanding whether probiotics play a role in athletic performance is of particular interest to athletes who work to improve their results in competition as well as reduce recovery time during training. Moreover, this knowledge may be relevant and of direct benefit to general human health.
The study of probiotic supplementation in athletes and physically active individuals is quite new with the first study in humans published by Clancy et al. [Citation53]. Over the last 13 years, the popularity and number of publications has increased substantially (see Table ). The number of products containing probiotics directed towards those that exercise is increasing.
The effect of probiotic supplementation on performance
Research specifically designed to investigate the effect of probiotic supplementation on performance has been less common and overall the results are mixed. Earlier studies that reported performance outcomes generally had primary aims related to immunity and GI health. Of the 24 studies that assessed some metric of athletic performance, 17 reported a null effect, while 7 reported significant improvement. However, more recent research indicates that probiotic supplementation can promote improvements in exercise performance through various pathways in athletes and physically active individuals using discrete strains of probiotics.
Some studies have used single probiotic strain interventions. For example, in a 16-week study investigating the effect of Lactobacillus fermentum VRI-003 on the immunity in 20 elite male distance runners, measures of performance (which included training duration, intensity, and VO2 max) did not change significantly [Citation57]. Similarly, in 80 competitive cyclists, 11 weeks of supplementation with L. fermentum (PCC®) had no effect on peak power or VO2 max [Citation61]. Four weeks of supplementation with Lactobacillus gasseri OLL2809 and alpha-lactalbumin in 44 university-student athletes did not improve cycle ergometer performance [Citation67]. Gill et al. [Citation75] did not find a difference in perception of effort during a treadmill test in eight male endurance-trained runners who supplemented with a high-dose of Lactobacillus casei (10 × 1010 CFU). Finally, in 39 elite athletes from various sports, 14 weeks of Lactobacillus helveticus Lafti L10 supplementation during the winter did not elicit significant differences in exercise performance as measured by VO2 max, treadmill performance time, maximal heart rate and heart rate recovery [Citation79]. The single strain interventions used in these five studies did not produce an aerobic performance benefit.
Null findings were similarly reported in several studies investigating the effects of multi-strain probiotics on aerobic performance. For instance, in endurance-trained men, 14 weeks of a multi-species probiotic had no effect on VO2 max and maximum performance [Citation63]. In a study designed to determine the effects of a 30-day period of supplementation with a 14-strain probiotic at rest, and in response to an acute bout of prolonged cycling exercise for 2 h at 60% VO2max in 11 active, healthy adults there was no significant change in rating of perceived exertion and heart rate [Citation73]. In another study assessing the effects of a multi-strain probiotic (along with 55.8 mg fructooligosaccharides, 400 mg alpha-lipoic acid, 600 mg N-acetyl-carnitine) in 30 recreational athletes over 12 weeks of progressive triathlon training no significant differences were found in race times [Citation77]. Marshall et al. [Citation81] investigated the effects of a multi-strain probiotic for 12 weeks of marathon training in a group of 32 marathon competitors and found no difference in marathon time to completion compared to the control group.
However positive results were reported in thirty endurance athletes supplementing with a yogurt drink, either containing Streptococcus thermophilus or Lactobacillus delbrueckii ssp. bulgaricus or no probiotics over 30 days during intense aerobic training. There was a significant increase in VO2max and aerobic power in the Cooper aerobic test [Citation45]. In thirty-three trained athletes, 12 weeks of winter training supplementation with a multi-species probiotic did not benefit athletic performance; however, the training load (hours per week) was higher in those who supplemented with the probiotic blend vs. the placebo group [Citation78]. One explanation for these findings could be that probiotics may enable better performance capabilities and training adherence when the risk of URTI development is reduced, as individuals with fewer episodes of infections such as common colds are able to train more often and harder. Further, Strasser et al. [Citation78], noted that the multi-species probiotic limited exercise-induced reductions in circulating tryptophan concentration. Higher serum tryptophan levels may enhance the tryptophan transport into the brain and support serotonin metabolism, which can influence an individual’s sensation of fatigue and thus potentially affect training adherence and performance [Citation91]. Interestingly, VO2max was positively correlated with pre-exercise serum tryptophan levels at a moderate magnitude, supporting a role of tryptophan metabolism in training performance.
Huang et al. [Citation85], found increased endurance performance and elevated blood glucose concentration following exercise-to-exhaustion after 6 weeks of high dose (1 × 1011 CFU) Lactobacillus plantarum TWK10 (a plant Lactobacillus strain isolated from Taiwanese pickled vegetables) supplementation in healthy male adults. However, as these were untrained males and no aerobic exercise intervention was reported in this study, these data should be interpreted conservatively in relation to endurance athletes. These results might be explained by an anti-inflammatory effect from L. plantarum TWK10 [Citation92] on skeletal muscle and improvement in energy harvest, possibly related to glycogenesis regulation for exercise demand. Interestingly, L. plantarum KX041 can maintain intestinal permeability and exert antioxidant capacity [Citation93]. Moreover, certain strains of L. plantarum activate cell growth signaling pathways in gut enterocytes which in turn increases protein metabolism in the gut [Citation94]. Further, L. plantarum can rescue the shunted growth phenotype in malnourished mice by activating muscle, bone, and organ growth [Citation95].
In a study investigating the effect of a multi-strain probiotic yogurt on performance in adolescent female endurance swimmers over 8 weeks, there was a significant improvement in VO2 max [Citation44]. The improvement in VO2 max was attributed to the reduction in number and duration of URTI for athletes following intake of the multi-strain probiotic yogurt. In another study researching the effect of multi-strain probiotics Shing et al. [Citation46] found 4 weeks of supplementation improved time to fatigue while running in the heat for ten male runners. While the mechanism for improvement was unclear, it was speculated that probiotics may exert small to large effects on GI structural integrity, endotoxin translocation and immune modulation that combine to enhance exercise performance. In contrast, a Kefir beverage (a naturally fermented milk beverage containing a defined mixed microbial culture of lactic acid bacteria and yeasts) consumed over 15 weeks of marathon training by sixty-seven male and female runners had no effect on 1.5 mile run test performance [Citation74]. Currently, there are more studies showing a benefit for multi-strain probiotics in relation to performance measures compared to single-strain probiotics. While there are some encouraging results, a large majority of studies have found no effect on aerobic performance. It appears that some of the positive benefits of probiotic supplementation may be indirect by allowing for improved gut integrity or immune modulation. However, additional research is warranted including investigating potential performance outcomes beyond aerobic-based endurance exercise.
Other studies have explored the effect of probiotic supplementation in relation to resistance training on muscle recovery and body composition. A pilot study in ten subjects using resistance trained males supplemented 20 g of casein protein with or without Bacillus coagulans GBI-30, 6086 (BC30) for 8 weeks following a periodized resistance training program showed a trend to increase vertical jump power [Citation71]. Jäger et al. [Citation43] speculated that the potential improvement in vertical jump performance may have been related to improved muscle recovery through gut microbial modulation. In a follow up study, 20 g of casein protein co-administered with B. coagulans GBI-30, 6086 (BC30) or a placebo in recreationally-trained individuals for 2 weeks increased recovery and decreased soreness after a muscle-damaging single-leg training bout [Citation43]. Furthermore, exercise-induced muscle damage was decreased as measured by serum creatine kinase, which may also indicate improved cellular integrity rather than damage per se. While not fully understood, candidate mechanisms of action included the production of digestive enzymes that are active under gut conditions (e.g. alkaline proteases) and these proteases can digest proteins more efficiently than the endogenous human proteases alone [Citation43, Citation96, Citation97]. Further, B. coagulans GBI-30, 6086 enhances the health of the cells of the gut lining through improved nutrient absorption including minerals, peptides, and amino acids by decreasing inflammation and encouraging optimum development of the absorptive area of the villi [Citation98]. In vitro, B. coagulans GBI-30, 6086 can increase protein absorption [Citation99]. The combination of B. coagulans GBI-30, 6086 with casein protein may have acted synergistically to augment digestion and modulate absorption.
In fifteen resistance-trained men, 3 weeks of Bifidobacterium breve BR03 and S. thermophilus FP4 supplementation improved isometric mean peak torque production and range-of-motion during acute recovery after a muscle-damaging elbow flexor exercise challenge in comparison to a control group [Citation42]. While mechanisms behind these observations were not described, these strains can have anti-inflammatory effects [Citation100–Citation102] and colonize in different areas of the GI tract. However, using the same strains and dose, Antonio et al. [Citation84], failed to see a significant effect on body composition in highly-trained men and women over a longer, six-week period. In both of the above studies participants were not provided supplemental protein. Toohey et al. [Citation103] investigated the effects of Bacillus subtilis DE111 probiotic supplementation on muscle thickness and strength, body composition, and athletic performance in Division I female volleyball and soccer athletes for 10 weeks of an offseason resistance training program. Both groups consumed a protein and carbohydrate recovery drink (consisting of 45 g carbohydrates, 20 g protein, and 2 g fat) immediately after each training session. Probiotic supplementation with the post-workout recovery drink yielded greater reductions in body fat and increases in fat free mass after 10 weeks of resistance training than a placebo. Although no performance advantages were observed, Toohey et al. [Citation103], speculated that supplementation may have promoted improved dietary protein absorption and utilization, contributing to improvements in body composition by increasing dietary protein-induced thermogenesis and altering satiety signaling. It seems that several strains of lactic acid bacteria, including L. gasseri SBT 2055, Lactobacillus rhamnosus ATCC 53103, and the combination of L. rhamnosus ATCC 53102 and Bifidobacterium lactis Bb12, are effective at reducing fat mass in obese humans [Citation104]. Additionally, other strains of B. breve have shown anti-obesity effects in both humans [Citation105] and mice [Citation106].
Townsend et al. [Citation83], evaluated the effect daily B. subtilis (DE111) supplementation on physical and performance adaptations in Division I collegiate baseball players following 12 weeks of offseason resistance training. On training days, placebo or probiotic capsules were consumed immediately post-workout with a protein and carbohydrate recovery drink (consisting of 36 g carbohydrates, 27 g protein, and 2 g fat). There were no group differences observed between those who took the probiotic and placebo for any measure of strength, performance, or body composition. However, those athletes who did supplement with probiotics had significantly lower serum TNF-α concentrations than the placebo group. Elevations in TNF-α have been linked to suppressed protein synthesis, disordered sleep, and impaired muscular performance [Citation107–Citation109]. The null performance findings reported by Townsend et al. [Citation83] and Antonio et al. [Citation84] may have been the result of an inability for the probiotic supplement to modify healthy participants’ microbiomes. Indeed, the subjects in these two studies were young, healthy and highly active. In this regard, systematic reviews [Citation110, Citation111] and an original investigation involving supplementation [Citation112] of probiotic supplementation in adults indicate that probiotic supplementation is more likely to alter the microbiome composition of dysregulated microbiomes compared to healthy ones. While probiotic consumption may not alter microbiome composition, it can alter functionality by up regulation of gene expression and metabolic pathways. As noted for aerobic performance, it is also plausible that probiotic supplementation confers an indirect effect on performance and that the training, diet, and recovery of the individuals in some of these studies were optimal enough to mask any small additional benefits.
The effect of probiotic supplementation on the immune system
The mucosal lining of the GI tract represents the first-line-of-defense against invading pathogens and is an important interface with the host immune system. Exhaustive physical exercise negatively impacts immunity, reducing of the count and function of immune cells, such as natural killer (NK) cells and T lymphocytes. Pro-inflammatory cytokines such as IL-1, TNF-α and IFN-γ generally remain unchanged after prolonged exercise whereas the inflammation-responsive cytokine IL-6 and anti-inflammatory cytokines such as IL-10, IL-1ra, sTNFR increase markedly. The increase in IL-6 is not solely in response to inflammation in this situation as it also originates from contracting muscle and is associated with glycogen regulation. Gene expression in white blood cells is upregulated for most anti-inflammatory markers and downregulated for pro-inflammatory markers and TLR signaling. The anti-inflammatory hormone cortisol is also elevated [Citation53, Citation57, Citation59, Citation113, Citation114]. Changes in immune health are associated with increased incidence of URTIs and disorders of the GI tract [Citation46, Citation53] which have the potential to impair physical performance and/or cause an athlete to miss training or competition [Citation115]. These conditions usually occur during competitive periods that are commonly represented by higher intensities and greater volumes of exercise [Citation116], affecting the athlete’s health and impairing physical performance when needed most [Citation115]. In this context, interventions that prevent or mitigate these conditions can indirectly improve physical and competition performance. Among the nutritional supplements used in modulation of the immune response of athletes, probiotics are noteworthy [Citation92].
Probiotics appear to augment intestinal communication between the host immune system and commensal bacteria to establish mutualistic benefits. The roles of microbial-derived SCFAs, particularly butyric acid in the colon, are important in mucosal homeostasis through regulation of epithelial turnover and induction of regulatory T (Treg) cells [Citation117]. Beyond the GI tract, probiotics have an immunomodulatory effect through the common mucosal immune system, in which cells from inductive sites (e.g., Peyer’s Patches in the intestines) translocate to mucosal surfaces following interaction with antigen-presenting cells [Citation118].
Research investigating the effects of probiotics on immune outcomes have been the most prevalent type of research in athletic populations. Of the 22 studies reviewed in this Position Stand that assessed the effect of probiotics on outcomes related to the immune system, 14 reported significant improvement, whereas 8 reported no effects.
Of particular relevance to athletes is the reduction in incidence and/or severity of symptoms from illnesses like URTI. In a large study of 465 active individuals who had a normal activity load of approximately 6 h per week, West et al. [Citation68] compared a single strain treatment consisting of Bifidobacterium animalis ssp. lactis Bl-04 and double-strain probiotic consisting of Lactobacillus acidophilus NCFM and B. animalis subsp. lactis Bi-07 to placebo over a 150-day intervention. Daily B. animalis ssp. lactis Bl-04 supplementation for 150 days was associated with a 27% reduction in the risk of any URTI episode compared to placebo supplementation. Supplementation with the double-strain probiotic resulted in a 19% decrease of URTI risk, although this was not statistically significant. Moreover, both probiotic supplement groups exhibited a ~ 0.8-month delay in time to illness. Importantly, healthy active individuals with a lighter training load, and presumably at a lower risk for URTIs, also appeared to benefit from a probiotic supplement.
The majority of studies that have investigated the potential benefits of probiotics on URTIs have been conducted in endurance athletes with generally high training loads. For example, Cox et al. [Citation57] studied the effect of L. fermentum VRI-003 (PCC) over 16 weeks of winter training in 20 elite male distance runners on incidence of illness and infection. Probiotic supplementation significantly reduced URTI incidence and severity compared to placebo. Specifically, those in the treatment group reported less than half the number of days of respiratory illness symptoms compared to the control group during the intervention. While not significant, there was a trend for enhanced T-lymphocyte function, which may be in part responsible for the immunological benefits. Similarly, Gleeson et al. [Citation60] examined the effects of Lactobacillus casei Shirota during 4 months of winter training in endurance-based recreational athletes and observed a significant reduction in URTIs compared to placebo. In addition, salivary IgA concentration was significantly higher in those consuming the probiotic. However, severity and duration of symptoms were similar between the treatment and placebo groups. Supplementation with the same strain 30 days prior to a marathon race resulted in improved systemic and airways immune responses, and showed a trend toward improved incidents and duration of URTI post-marathon [Citation90]. In competitive cyclists, West et al. [Citation61] reported reduced severity of self-reported symptoms of lower respiratory illness and use of cold and flu medication over an 11-week winter training period with L. fermentum (PCC®) compared to placebo. Interestingly, this effect was only noted in males and not females. Strasser et al. [Citation78] examined the effect of 12 weeks of treatment with a multi-strain probiotic on the incidence of URTIs and metabolism of aromatic amino acids after exhaustive aerobic exercise in highly trained athletes during the winter. Daily supplementation with probiotics reduced the incidence of URTI compared to placebo. In addition, supplementation limited exercise-induced reductions in tryptophan levels, which may reduce the risk of developing an infection.
Beyond studies investigating traditional endurance athletes with high aerobic training loads, probiotic supplementation has also been examined in other athletes with varying demands. For instance, Salarkia et al. [Citation44] reported that 8 weeks of supplementation with a multi-strain probiotic yogurt reduced the number of episodes of URTIs in adolescent female swimmers compared to the same yogurt without probiotics. Haywood et al. [Citation69] investigated the effect of a multi-strain probiotic over 4 weeks in 30 elite union rugby players to determine effectiveness on the number, duration and severity of infections. The probiotic group had lower incidence of infection-related symptoms compared to placebo, although there was no difference in the severity of the symptoms between the two treatment groups. In a study of an eclectic group of elite athletes training in badminton, triathlon, cycling, alpinism, athletics, karate, savate, kayak, judo, tennis, and swimming, Michalickova et al. [Citation79] studied the effects of L. helveticus Lafti L10 over 14 weeks during the winter. Athletes all had high training loads of > 11 h per week and were winners of the national or European and world championships in their categories and sport. Supplementation with the probiotic significantly reduced the length of URTI episodes and lowered the number of symptoms per episode compared to placebo. Moreover, there was a significant increase of CD4+/CD8+ (T helper/T suppressor) cells ratio in the probiotic group. Previously, this ratio has been noted as an index sensitive to high training loads and was decreased after strenuous physical activity [Citation36, Citation119]. In addition, low CD4+/CD8+ cell ratio is usually related to acute viral diseases [Citation120].
Several studies that assessed similar outcomes did not report significant effects from probiotic supplementation compared to placebo. For example, a 12-week study on 141 non-elite marathon runners during pollen season supplementing daily with L. rhammnosus GG (LGG) did not find a significant effect on allergic markers [Citation54] or on the incidence of UTRI episodes [Citation55]. Similarly, there was no significant effect on URTI incidence in a study investigating the effect of L. casei supplementation in French soldiers participating in intense military training for 3 weeks in a 5-day combat course [Citation56]. In addition, there was no difference in salivary IgA or total and differential leukocyte and lymphocyte subsets.
Gleeson et al. [Citation64] examined the effects of daily supplementation of L. salivarius on 66 endurance-based recreational athletes during a four-month period in the spring. There was little effect on frequency, severity or duration of URTIs. In addition, circulating and salivary immune markers did not change over the course of the study and were not different between probiotic and placebo groups. Gleeson et al. [Citation80] also assessed the effect of L. casei Shirota on the incidence of URTIs over a 20-week period during the winter in 243 college endurance athletes. Similarly, there was no significant difference between those that consumed the probiotic and the placebo treatment. However, there was a reduction in plasma cytomegalovirus and Epstein Barr virus antibody titers in seropositive athletes compared to placebo, an effect interpreted as a benefit to overall immune status.
While these null findings are important to consider, the current overall body of evidence is weighted notably in favor of probiotics on reduction of URTIs and related symptoms. However, a central issue in relation to the effects of probiotics on immunity, and probiotic research in general, is the large assortment of strains used. Shared, core mechanisms for probiotic function are evident, although some mechanisms may be more narrowly distributed, including those related to immunomodulation [Citation121]. In addition, it is important to note that immune response is complex, as are many of the methodologies used to measure it. For example, an immunomodulatory effect of probiotics is attributed to the release of a large number of cytokines and chemokines from immune cells, which can further impact the innate and adaptive immune systems [Citation122]. Therefore, it is not surprising that the beneficial effect of probiotic administration on the incidence of respiratory illness is possibly linked enhancement of systemic and mucosal immunity. It is possible changes occurred at this level and were not detected in studies that only measured URTI associated metrics. Future work in this area should pair the investigation of URTI incidence and symptomology with other markers of immune response to provide a more thorough understanding of how different probiotics might influence the immune system.
Although less common than symptom outcomes, several studies have provided encouraging evidence in regard to changes in circulating and salivary immune markers. For instance, Clancy et al. [Citation53] sought to determine if immune variables differed between healthy and fatigued recreational athletes after Lactobacillus intervention. One month of daily L. acidophilus supplementation significantly increased secretion of interferon (IFN)-γ from T cells in fatigued athletes to levels found in healthy athletes and increased the concentration of IFN-γ in saliva of healthy control athletes. IFN-γ is a cytokine intricately linked to mechanisms of control of both virus shedding and disease re-activation. Sashihara et al. [Citation67] evaluated the immunopotentiation and fatigue-alleviation effects of L. gasseri OLL2809 supplementation for 4-weeks in 44 university-student athletes. Before and after the treatment period, the subjects performed strenuous cycle ergometer exercise for 1 h. The probiotic supplementation prevented reduced NK cell activity after strenuous exercise which may enhance resistance against infections. In another short-term study, Aghaee et al. [Citation70] reported that a probiotic supplement for 30 days in 16 male athletes increased blood monocyte levels following exhaustive exercise in comparison to placebo control. In a longer duration study, Michalickova et al. [Citation79] investigated the effects of L. helveticus Lafti L10 supplementation on systemic humoral and mucosal immune response in 30 elite athletes with a high training load (> 11 h per week) over 14 weeks in the winter. Those that consumed the probiotic exhibited attenuated decreases in total salivary IgA level compared to athletes in the placebo group. Given the fact that mucosal surface is the first-line-of-defense against different pathogens, this finding might have a practical application in terms of prevention of URTIs during strenuous exercise in elite athletes. In comparison to some of the previous studies that didn’t report changes in immune parameters, yet noted a difference in URTI incidence, it is possible that in these circumstances these strains could have displayed antagonistic activities against pathogens and not direct stimulation of the immune system. These effects could include the production of antimicrobials, such as bacteriocins, and low molecular weight compounds such as hydrogen peroxide, lactic acid, and acetic acid [Citation123–Citation125]. These substances could function to outcompete pathogenic bacteria and help in easing or preventing URTI symptoms [Citation126].
In contrast, West et al. [Citation66] did not find significant effects of a synbiotic product including multi-strain probiotics (Lactobacillus paracasei ssp. paracasei (L. casei 431®), B. animalis ssp. lactis (BB-12®), L. acidophilus LA-5, L. rhamnosus GG) on markers of circulating and mucosal immunity in 22 recreational cyclists over a three-week training period. In another small study of the effects of a multi-strain probiotic (L. acidophilus, L. delbrueckii ssp. bulgaricus, Lactococcus lactis ssp. lactis, L. casei, L. helveticus, L. plantarum, L. rhamnosus, L. salivarius ssp. salivarius, B. breve, Bifidobacterium bifidum, B. infantis, Bifidobacterium longum, B. subtilis, and S. thermophilus) on mucosal immunity, Muhamad & Gleeson [Citation73] did not report a significant alteration in salivary antimicrobial proteins at rest or in response to an acute bout of prolonged exercise in 11 active, healthy adults after 30 days of supplementation. Using a high-dose probiotic treatment, Gill et al. [Citation75] studied 8 male endurance runners who consumed 10 × 1010 CFU of L. casei for 7 days prior to a two-hour running exercise at 60% VO2max in hot ambient conditions (34.0 °C and 32% relative humidity). Supplementation did not enhance salivary antimicrobial proteins responses and subsequent oral-respiratory mucosal immune status above placebo. Finally, Carbuhn et al. [Citation86] explored the effects of B. longum 35,624 supplementation in 20 female Division I collegiate swimmers during a 6-week intense training phase on IgA. There were no difference in salivary IgA between groups throughout the study in agreement with a study investigating B. subtilis DE111 in collegiate baseball players [Citation83].
Overall, the effect of probiotic supplementation on the immune system in athletes is likely positive and beneficial. Episodes of illness often occur during heavy exercise training periods, a time when athletes obtain the greatest improvements in fitness. Illness that interrupts individual training sessions may prevent athletes from maximizing the effects of their training program. Therefore, probiotic supplementation may be viewed as a viable dietary supplement to support immune function during these periods.
The effect of probiotic supplementation on GI tract health
GI problems often occur in endurance athletes and particularly during prolonged events such as cycling, triathlons and marathons [Citation41, Citation127]. Symptoms such as nausea, cramping, bloating, and diarrhea most likely reflect redistribution of blood flow from the gut to the skin for cooling purposes. Exercise-induced redistribution of blood can result in splanchnic hypoperfusion as a possible mechanism for gut dysfunction [Citation128, Citation129]. The physical up-and down movement of the gut during running could also explain an increase in the frequency of gut symptoms [Citation41]. Interactions between prolonged exercise, challenging environmental conditions (temperature, altitude, humidity, etc.), and nutrient and fluid intake may also increase risk of gut problems [Citation130]. Disruption in the GI system can impair the delivery of nutrients, and cause GI symptoms and decreased performance. The GI tract and particularly the gut are quite adaptable and can be targeted to improve the delivery of nutrients during exercise while at the same time alleviating some (or all) of the symptoms [Citation131]. A major limitation of studies in this field is that the prevalence of GI illnesses overall is quite low, which makes it difficult to study without a large number of subjects. Probiotic supplementation in combination with other dietary strategies (e.g. consuming well-tolerated foods and drinks, avoiding spicy foods) could assist athletes with a history of GI problems. Moreover, probiotic supplementation potentially could improve GI health which has several indirect athletic benefits. Of the ten studies that assessed GI benefit in athletes and physically active individuals, the majority reported no effect. However, the methodology varied considerably, including probiotic type (species/strain), dosing, duration and study participants, making comparison difficult. Further, the overall result is not conclusive as four studies reported positive results. This latter group included significantly decreased concentrations of zonulin [Citation63] and endotoxin [Citation77], as well as intestinal hyperpermeability [Citation132] and duration of GI-symptom episode. Research in this area has only been conducted intermittently over the past 10 years, with the need for future studies apparent.
In the first reported study investigating the effects of probiotics on GI health, Kekkonen et al. [Citation55], reported no effect of L. rhamnosus GG on GI-symptom episodes in marathon runners after a three-month training period. However, the duration of a GI symptom episode was 57% shorter in the probiotic group than in the placebo group. Eight weeks of supplementation with a multi-strain probiotic yogurt in adolescent female endurance swimmers did not affect GI symptoms [Citation44]. In a study of elite union rugby players, subjects given a multi-strain probiotic over 4 weeks did not experience a significant reduction in GI episodes (including nausea, vomiting, diarrhea) compared to the placebo [Citation69].
Investigating markers of gut permeability, West et al. [Citation66] found no significant effect of multi-strain probiotic supplementation on the lactulose/mannitol ratio in active individuals after 3 weeks. Lamprecht et al. [Citation63] explored the effects of 14 weeks of multi-species probiotic supplementation on zonulin from feces in trained men. Zonulin concentrations decreased significantly from slightly above normal into the physiological range in subjects that supplemented with the probiotics. Zonulin is a protein of the haptoglobin family released from liver and intestinal epithelial cells and has been described as the main physiological modulator of intercellular tight junctions [Citation133]. Increased zonulin concentrations are related to changes in tight junction competency and increased GI permeability [Citation133]. The “leak” in the paracellular absorption route enables antigens to pass from the intestinal environment, challenging the immune system to produce an immune response and subsequent inflammation and oxidative stress [Citation134–Citation136]. Lamprecht et al. [Citation63] suggested that the supplemented probiotics may activate the TLR2 signaling pathway resulting in improved intestinal barrier function, thus reducing an athlete’s susceptibility to endotoxemia and associated cytokine production [Citation137].
Shing et al. [Citation46] tested the effects of 4 weeks of multi-strain probiotics supplementation on GI permeability when exercising in the heat in a small group of male runners. To assess GI permeability, subjects ingested lactulose and rhamnose before exercise and post-exercise urine was collected to measure the ratio. Further, urinary claudin-3, a surrogate marker of gut barrier disruption, and serum lipopolysaccharide (LPS) were measured. There was no significant effect on lactulose:rhamnose ratio, urinary claudin-3 or serum LPS and it is possible that 4 weeks may not have been sufficient to detect changes. In short-term, high dose single-strain probiotic supplementation (L. casei), male runners under heat stress did not exhibit any marked changes in resting circulatory endotoxin concentration or plasma cytokine profile compared with placebo [Citation76]. Conversely, Roberts et al. [Citation77] reported 12 weeks of supplementation with a multi-strain probiotic/prebiotic significantly reduced endotoxin levels in novice distance triathletes. However, no difference was identified in the assessment of intestinal permeability from urinary lactulose:mannitol ratio. This effect was reported both pre-race and 6 days post-race. Additionally, seven highly-trained endurance athletes who received 4 weeks of L. salivarius (UCC118) attenuated exercise-induced intestinal hyperpermeability [Citation132]. Most recently, 12 weeks of probiotic supplementation (B. subtilis DE111) had no effect on gut permeability as measured by zonulin in Division I baseball players [Citation83].
Mechanism of action
Given that different strains and product formulations exist, explaining the mechanism of action becomes a rather complex task. An additional challenge in probiotic research is that a mechanism of action involving the gut microbiota is not confirmed, or even examined, in the majority of cases and there certainly are mechanisms outside of the GI tract systemically and in other microbiota niches. Clinical studies track probiotic “inputs” (whether a single strain or multiple strains) and health “outputs”, often without knowing what happens in between. This shortcoming further emphasizes the need to not use the general term probiotics, when describing mechanisms of action, but try to specify the strains [Citation138]. This does not mean the mechanisms are the same for each strain, nor that precise mechanisms have been proven. For example, bacterial strains such as L. reuteri SD2112 (ATCC 55730) and L. reuteri RC-14 are different genetically and functionally, with the former producing reuterin believed to be important for inhibition of pathogens in the gut [Citation139] and the latter producing biosurfactants that inhibit attachment of uropathogens [Citation140]. Finally, several food products and dietary supplements may contain multiple species and strains in the same product. To fully explain the in-depth mechanisms of action is both out of the scope of this Position Statement and poorly understood in general. However, interested readers are directed to other resources [Citation138, Citation141]. The question whether multi-strain or multi-species probiotics are better than single strain or single species probiotics depends on the outcome measure, dosage, and study population. Potential additive or even synergistic benefits would need to be validated in a control clinical study, and currently those data do not exist. Mechanisms of action in relation to the effects of probiotic supplementation in athletes has been less described [Citation40]. Here we discuss support of the gut epithelial barrier, increased adhesion to intestinal mucosa, the effects of postbiotics, modulation of the immune system, and improved nutrient absorption.
Support of the gut epithelial barrier
The intestinal barrier is a major defense mechanism used to maintain epithelial integrity and protect the host from the environment. Defenses of the intestinal barrier consist of the mucous layer, antimicrobial peptides, secretory IgA and the epithelial junction adhesion complex [Citation142]. Once this barrier function is disrupted, bacterial and food antigens can reach the submucosa and induce inflammatory responses [Citation143, Citation144]. Consumption of non-pathogenic bacteria can contribute to intestinal barrier function, and probiotic bacteria have been extensively studied for their involvement in the maintenance of this barrier. However, the mechanisms by which probiotics enhance intestinal barrier function are not fully understood. Anderson et al. [Citation145] indicated that enhancing the expression of genes involved in tight junction signaling is a possible mechanism to reinforce intestinal barrier integrity. Probiotics may promote mucous secretion as one mechanism to improve barrier function and the exclusion of pathogens. Several Lactobacillus species have been noted to increase mucin expression in human intestinal cell lines and, in the case of a damaged mucosa, may thus help restoration of the mucus layer. However, this protective effect is dependent on Lactobacillus adhesion to the cell monolayer, which likely does not occur in vivo [Citation146, Citation147]. Therefore, mucous production may be increased by probiotics in vivo, but further studies are needed to make a conclusive statement.
Strenuous and prolonged exercise place stresses on the GI tract that increase the likelihood of discomfort, abdominal cramping, acid reflux (heartburn), nausea, vomiting, diarrhea, and permeability of the gut that may allow endotoxemia to occur [Citation41]. Splanchnic hypoperfusion leading to ischemia in the gut is accepted as a principal cause, with additional contributions from nutritional, mechanical (e.g., jarring), and genetic influences that make some individuals more susceptible than others [Citation41]. Probiotic support to increase resilience of the GI tract against ischemia is of interest to athletes, particularly for those involved in prolonged endurance events that have the greatest occurrence of GI problems that can impair or stop performance. Mechanistically, prolonged or strenuous exercise may increase key phosphorylation enzymes [Citation148], disrupting tight junction proteins claudin (influenced by protein kinase A) and occludin (influenced by both protein kinase C and tyrosine kinase). Acute changes in tight junction permeability and paracellular transport may lead to a greater prevalence of systemic LPS. LPS from Gram-negative intestinal bacteria may provoke immune responses and endotoxin-associated symptoms characteristic of GI complaints often experienced in runners [Citation148]. Despite this, research is relatively sparse on whether prolonged training or ultra-endurance events actually result in elevated LPS, particularly in more “recreationally active” athletes; or whether targeted nutrition strategies offer beneficial support. LPS translocation across the GI tract can provoke systemic immune reactions with varied consequences [Citation149]. Specifically, LPS attachment to LPS-binding protein and its transference to an MD 2/TLR4/CD14 complex activates NF-κB and various inflammatory modulators (TNF-α, IL-1β, IL-6 and CRP). This sequence is considered a protective mechanism to minimize bacterial entry across the GI tract. Under normal physiological conditions, endotoxins from gram negative bacteria are usually contained locally, with only relatively small quantities entering the systemic circulation. However, when GI defenses are either disrupted (i.e., luminal damage from exercise) or LPS “sensing” is “overloaded”, a heightened inflammatory response may result which could, in part, relate to GI symptoms associated with exercise [Citation150]. This effect could have implications for daily recovery strategies throughout prolonged training periods, and in the days following ultra-endurance events.
Roberts et al. [Citation77] suggested a multi-strain pro/prebiotic intervention maintains tight junction stability. Further, studies have demonstrated that regular use of probiotics can improve epithelial resistance by establishing competitive “biofilm” formation. Indeed, as LPS types vary across Gram-negative bacteria species, some LPS are poorly sensed by TLR4 and may have more direct impact on NF-κB activation [Citation151]. Therefore, prevention of LPS translocation through maintained epithelial integrity and/or increased preponderance of Gram-positive genera may offer potential therapeutic benefit [Citation152]. Specifically, the provision of bacteria belonging to the Lactobacillus genus may work by activating TLR2 and hence produce more favorable innate immune responses [Citation153, Citation154]. Supplementation with a multi-strain probiotic for 14 weeks decreased fecal zonulin levels, supporting improved tight junction stability through improved intestinal barrier integrity [Citation63]. A mechanistic explanation for an improved intestinal barrier function after probiotic treatment is provided by Karczewski et al. [Citation155], who postulate that certain lactic bacteria might activate the TLR2 signaling pathway. TLR2 is localized in the membranes of intestinal wall cells and from there communicates with microbial products from Gram-positive bacteria [Citation115]. Furthermore, activation of the TLR2 signaling pathway can enhance epithelial resistance in vitro [Citation156]. Therefore, supplemented probiotics may suppress bacteria that activate the zonulin system (e.g. Gram-negative bacteria), settle in the deep intestine, and activate the TLR2 signaling pathway.
Adhesion to intestinal mucosa
“Competitive exclusion” is a term used to describe the vigorous competition of one species of bacteria for receptor sites in the intestinal tract over another species. The mechanisms used by one species of bacteria to exclude or reduce the growth of another species include: creation of a hostile microecology, elimination of available bacterial receptor sites, production and secretion of antimicrobial substances and selective metabolites, and competitive depletion of essential nutrients [Citation141]. Adhesion of probiotics to the intestinal mucosa has been shown to favorably modulate the immune system [Citation157, Citation158] and pathogen antagonism [Citation159]. In addition, probiotics are able to initiate qualitative alterations in intestinal mucins that prevent pathogen binding [Citation160] while some probiotic strains can also induce the release of small peptides or proteins (i.e., defensins) from epithelial cells [Citation161]. These small peptides/proteins are active against bacteria, fungi and viruses [Citation162] and may stabilize the gut barrier function [Citation163]. Specific adhesiveness properties related to the interaction between surface proteins and mucins may inhibit the colonization of pathogenic bacteria and are a result of antagonistic activity by some strains of probiotics against adhesion of GI pathogens [Citation164]. For example, lactobacilli and bifidobacteria can inhibit a broad range of pathogens, including E. coli, Salmonella, Helicobacter pylori, Listeria monocytogenes, and Rotavirus [Citation165–Citation171]. To gain a competitive advantage, bacteria can also modify their environment to make it less suitable for their competitors, such as producing antimicrobial substances (i.e., lactic and acetic acid) [Citation172]. Some lactobacilli and bifidobacteria share carbohydrate-binding specificities with certain enteropathogens [Citation173, Citation174], which makes it possible for the strains to compete with specific pathogens for the receptor sites on host cells [Citation175]. In general, probiotic strains are able to inhibit the attachment of pathogenic bacteria by means of steric hindrance at enterocyte pathogen receptors [Citation176].
Postbiotics
Postbiotics comprise metabolites and/or cell-wall components released by probiotics and offer physiological benefits to the host by providing additional bioactivity [Citation4]. The potential benefits of these metabolites and/or cell wall components should not only be considered to be associated with probiotics but more generally to metabolites produced by bacteria during fermentation, including bile acid fermentation. Several compounds have been collected from several bacteria strains including SCFAs, enzymes, peptides, teichoic acids, peptidoglycan-derived muropeptides, endo- and exo-polysaccharides, cell surface proteins, vitamins, plasmalogens, and organic acids [Citation177–Citation179]. Despite the fact that the mechanisms implicated in the beneficial health effects of postbiotics are not fully elucidated, they possess different functional properties including, but not limited to, antimicrobial, antioxidant, and immune modulation [Citation4]. These properties can positively affect the microbiota homeostasis and/or the host metabolic and signaling pathways, physiological, immunological, neuro-hormone biological, regulatory and metabolic reactions [Citation180, Citation181].
In the majority of cases, postbiotics are derived from Lactobacillus and Bifidobacterium species; however, Streptococcus and Faecalibacterium species have also been reported as a source of postbiotics [Citation177, Citation179]. SCFAs produced by the gut microbiota act as signaling molecules improving regulation of lipid metabolism, glucose homeostasis, and insulin sensitivity through the activation of receptors such as G protein-coupled receptors (GPRs) to regulate of energy balance while maintaining metabolic homoeostasis [Citation182, Citation183]. Specific SCFAs (e.g. butyrate, acetate and propionate) also contribute to plasma cholesterol homeostasis in rodents and humans [Citation184]. Some studies [Citation185–Citation187] determined that cell-free extracts from lactic acid bacteria exhibit higher antioxidant capacity than whole cell cultures, suggesting that the antioxidant capacity could be attributed to both enzymatic and non-enzymatic intracellular antioxidants.
Through postbiotic action, it seems plausible that probiotics can increase exercise performance as seen through a delay in fatigue in athletes by virtue of their production of SCFAs. In addition, species within the Lactobacillus genus synthesize lactic acid, which is converted to butyrate and later to acetyl-CoA, which is used in the Krebs Cycle to generate adenosine triphosphate (ATP). However, these processes occur mostly in the gut so whether or not this would impact skeletal muscle performance remains to be determined [Citation188]. Another mechanism is by antioxidant action, which can attenuate muscle injury induced by reactive oxygen species, among others [Citation92]. Antioxidant effects found in probiotics are linked to the synthesis of antioxidant substances such as vitamins B1, B5 and B6 [Citation141]. Moreover, probiotic supplementation reduces the risk of developing hyperglycemia, a condition known to be linked to oxidative stress [Citation189, Citation190]. Finally, the improvement in intestinal homeostasis, including the absorption process, may favor the absorption of antioxidants, increasing the availability of these substances [Citation58].
One of the proposed mechanisms involved in the health benefits afforded by probiotics includes the formation of low molecular weight compounds (< 1000 Da), such as organic acids, and the production of antibacterial substances termed bacteriocins (> 1000 Da). Organic acids, in particular acetic acid and lactic acid, have a strong inhibitory effect against Gram-negative bacteria, and are considered the main antimicrobial compounds responsible for the inhibitory activity of probiotics against pathogens [Citation191–Citation193]. The undissociated form of the organic acid enters the bacterial cell and dissociates inside its cytoplasm. The eventual lowering of the intracellular pH or the intracellular accumulation of the ionized form of the organic acid can lead to the death of the pathogen [Citation194].
Intestinal bacteria also produce a diverse array of health-promoting fatty acids. Certain strains of intestinal bifidobacteria and lactobacilli can produce conjugated linoleic acid (CLA), a potent anti-carcinogenic agent [Citation195, Citation196]. An anti-obesity effect of CLA-producing L. plantarum has been observed in diet-induced obesity in mice [Citation197]. Recently, the ability to modulate the fatty acid composition of the liver and adipose tissue of the host upon oral administration of CLA-producing bifidobacteria and lactobacilli has been demonstrated in a murine model [Citation196]. Finally, certain probiotic bacteria are able to produce so-called de-conjugated bile acids, which are derivatives of bile salts. De-conjugated bile acids show a stronger antimicrobial activity compared to that of the bile salts synthesized by the host organism [Citation141].
Modulation of the immune system
Numerous studies have shown that prolonged intense physical exercise is associated with a transient depression of immune function in athletes. While moderate exercise beneficially influences the immune system [Citation198], a heavy schedule of training and competition can impair immunity and increase the risk of URTIs due to altered immune function [Citation116, Citation199, Citation200]. Both innate immunity and acquired immunity are decreased following prolonged exercise [Citation199–Citation201]. It is well known that probiotic bacteria can exert an immunomodulatory effect; however, research from non-athletic populations may not be translatable to athletes. Further, the manipulation and control of the immune system by probiotics is difficult to evaluate and make general conclusions. However, several studies investigating the effects of probiotics in athletes have reported improvement in low-grade inflammation [Citation42, Citation63], as well as increased resistance to URTIs [Citation57, Citation60, Citation69, Citation78] and reduced duration of URTI [Citation79].
Modulation of the immune system to increase defenses against URTIs currently is the most extensively researched area. The GI tract is a major gateway for pathogen entry, and as such, is heavily protected by the immune system. The immune system can be divided between the innate and adaptive systems. The adaptive (acquired) immune response depends on B and T lymphocytes, which are specific for particular antigens. In contrast, the innate immune system responds to common structures called pathogen-associated molecular patterns (PAMPs) shared by the vast majority of pathogens [Citation202]. The primary response to pathogens is triggered by pattern recognition receptors (PRRs), which bind PAMPs. The best-studied PPRs are TLRs. In addition, extracellular C-type lectin receptors (CLRs) and intracellular nucleotide-binding oligomerization domain-containing protein NOD-like receptors are known to transmit signals upon interaction with bacteria [Citation203]. It is well established that probiotics can suppress intestinal inflammation via the downregulation of TLR expression, secretion of metabolites that may inhibit TNF-α from entering blood mononuclear cells, and inhibition of NF-ĸB signaling in enterocytes [Citation202].
Probiotics can enhance innate immunity (first-line-of-defense) by upregulating immunoglobulins, antimicrobial proteins, phagocytic activity, and natural killer cell activity, and enhance acquired immunity by improving antigen presentation and function of T and B lymphocytes to neutralize pathogens and virally-infected cells [Citation10, Citation204]. These effects are of particular importance to athletes because exercise may increase susceptibility to URTIs by decreasing salivary IgA, decreasing cell-mediated immunity by decreasing type 1 T lymphocytes to make recurrent infections more likely, and increasing glucocorticoid suppression of monocyte/macrophage antigen presentation and T lymphocyte functions [Citation205, Citation206]. The majority of placebo-controlled clinical trials assessing the efficacy of probiotics for reducing incidence, duration, and severity of URTI in athletes report beneficial outcomes. However, many different probiotics have been used and the differences in trial protocols and outcome measures complicate the drawing of more specific conclusions.
Improved nutrient absorption
Supplementation with some probiotic strains has been suggested to improve dietary protein absorption and utilization [Citation207]. While not fully elucidated, several studies indicate a plausible role [Citation208], yet a clear mechanism of action is lacking. As noted, probiotics can potentially improve intestinal barrier function by modulating tight junction permeability which may improve nutrient absorption.
Improving the digestibility of protein can speed recovery of strength after muscle-damaging exercise [Citation209], and promote glycogen replenishment after exercise. B. coagulans produce digestive enzymes [Citation97] active under gut conditions (alkaline proteases). These proteases can digest proteins more efficiently than the endogenous human proteases alone [Citation96]. B. coagulans GBI-30, 6086 enhances the health of the cells of the gut lining improving nutrient absorption including minerals, peptides, and amino acids by decreasing inflammation and encouraging optimum development of the absorptive area of the villi [Citation98].
In a computer-controlled in vitro model of the small intestine, B. coagulans GBI-30, 6086 enhanced amino acid absorption while improving colon health [Citation208]. In recreationally-trained males, Jäger et al. [Citation43] found the co-administration of B. coagulans GBI-30, 6086 and 20 g of protein improved recovery 24 and 72 h, and muscle soreness 72 h post-exercise. Furthermore, Toohey et al. [Citation103], noted B. subtilis DE111 supplementation with a post-workout recovery drink containing 20 g of protein reduced body fat percentage after 10 weeks of resistance training compared with the same post-workout recovery drink and a placebo in female athletes. Toohey et al. [Citation103] speculated improved amino acid uptake in the probiotic group may have resulted from more efficient protein digestion, simulating the effects of a higher daily protein intake.
Safety and health
The concept of probiotics is not new. Around 1900 Nobel laureate, Elie Metchnikoff, discovered that the consumption of live bacteria (L. bulgaricus) in yogurt or fermented milk improved some biological features of the GI tract [Citation210]. Bacteria with claimed probiotic properties are now widely available in the form of foods such as dairy products and juices, and also as capsules, drops, and powders. Probiotics have been used safely in foods and dairy products for over a hundred years. Some of the most common commercially available strains belong to the Lactobacillus and Bifidobacterium genera. In this respect, well-studied probiotic species include Bifidobacterium (ssp. adolescentis, animalis, bifidum, breve, and longum) and Lactobacillus (ssp. acidophilus, casei, fermentum, gasseri, johnsonii, reuteri, paracasei, plantarum, rhamnosus, and salivarius) [Citation211]. An international consensus statement in 2014 indicated that these are likely to provide general health benefits such as normalization of disturbed gut microbiota, regulation of intestinal transit, competitive exclusion of pathogens, and production of SCFAs [Citation1].
Beyond athletes and physically active individuals, there is a large body of preclinical and clinical research on the GI benefits of probiotics in healthy individuals and in a wide range of health conditions. These applications include treatment and prevention of acute diarrhea, prevention of antibiotic-associated diarrhea, treatment of hepatic encephalopathy, symptomatic relief in irritable bowel syndrome, and prevention of necrotizing enterocolitis in preterm infants [Citation212]. Overall, probiotics have an excellent safety profile with a large majority of clinical trials involving probiotics not giving rise to major safety concerns [Citation213]. Of the adverse events (AEs) commonly reported, Marteau [Citation214] outlined four classes of possible side effects of probiotic use: systemic infections, detrimental metabolic effects, cytokine-mediated immunologic adverse events in susceptible individuals, and transfer of antibiotic resistance genes. Of these, particular concern relates to probiotics potential to create (not improve or treat) systemic infections [Citation49, Citation64, Citation215]. Further, probiotics have been studied in vulnerable groups, including infants, patients with severe acute pancreatitis, inflammatory bowel diseases, liver diseases, HIV, and other conditions [Citation213, Citation216–Citation218] with even greater cause for concern with the small number of products that contain high concentrations of up to 450–900 billion live bacteria per dose [Citation211]. Many of the studies reporting AEs (rarely serious AEs) either do not utilize the appropriate biological sampling and identification techniques or AEs are poorly reported.
Commercially available probiotic products can be divided into single-strain (defined as containing one strain of a well-defined microbial species) and multi-strain (containing more than one strain of the same species or genus). The term multispecies is also used for products that contain strains from more than one genus [Citation211], for example a product with a L. acidophilus strain, a L. reuteri strain, and a B. longum strain. Treatment with probiotics may involve the consumption of large quantities of bacteria, so safety is a primary concern. There are two aspects to safety: establishing the adverse effect profile of specific single-strain and multi-strain supplements (i.e., the safety of the strain(s) per se), and ensuring that marketed supplements meet stringent quality standards to ensure the correct strains are present and the product is free of contamination [Citation217].
Safety assessments should take into account the nature of the specific probiotic microbe, method of administration, level of exposure, health status of the recipients, and the physiological functions the microbes are intended to perform [Citation213]. However, most probiotics in commercial use are derived from fermented foods with a long history of safe consumption, or from microbes that may colonize healthy humans [Citation212]. All common probiotic species are considered safe for the general population by the European Food Safety Authority (EFSA), although this definition does not provide guidance on the increasing use of probiotics in people with medical conditions. Moreover the benefits of probiotics are not validated by EFSA, jeopardizing the use of the term probiotic without an approved claim with some exceptions such as in Italy, Czech Republic, and Bulgaria [Citation211]. Going beyond history of safe use, since 2007 the EFSA lists species presumed safe for human consumption under the “Qualified Presumption of Safety” (QPS) concept. The approach is based on experience that for selected organisms there are no reasonable safety concerns for human health. The list regularly monitors the body of knowledge through extensive scientific literature review, applied to a wide array of micro-organisms added in the food-chain. The QPS list concerns consumption by the general healthy population and does not take into consideration potential risks for vulnerable populations and this is clearly mentioned. The U.S. Food and Drug Administration (FDA) classifies probiotics individually but has classified many as Generally Recognized As Safe (GRAS), safe for the use in foods and infant products [Citation219].
A systematic literature review of probiotic safety published in 2014 reported that “the overwhelming existing evidence suggests that probiotics are safe” for the general population, and that critically ill patients, postoperative and hospitalized patients and immunocompromised patients were the most at-risk groups wherein AEs occurred [Citation220]. The general consensus is that probiotic ingestion is safe [Citation221, Citation222], with large doses well tolerated and failing to exhibit any toxicity [Citation223]. Indeed, low CFU dosage and intervention periods between 2 weeks to 6 months are generally used within clinical research models [Citation224, Citation225]. In this position stand, which reviews studies focused on probiotic supplementation in athletes and physically active individuals, 11 studies measured AEs and general supplementation tolerance, while 30 studies did not. Of the 11 studies, a general consensus was made to conclude that probiotic supplementation was generally well tolerated with a very low level of adverse health effects. There was one instance in which mild GI symptoms (5 episodes) were reported, including flatulence and stomach rumbles during supplementation with a multi-strain probiotic in 22 active individuals [Citation66]. AEs are often not well recorded in nutritional studies in general and probiotics are no exception to this. Overall, from the current body of research probiotic supplementation for healthy athletes and physically active individuals appears safe. Caution is warranted for those with serious health conditions, such as severe acute pancreatitis, inflammatory bowel diseases, liver diseases, and HIV. In these instances, it is advised that the patient consult with their health care practitioner before supplementing. Another consideration is supplementing evidence-based dosages and keeping the probiotic properly stored. Unlike, other familiar sports supplements, probiotics are live organisms and may require specific storage requirements including refrigeration.
Regulation
Currently there is no clear set of recommendation or guidelines on probiotic use for athletes. The current body of research has investigated a wide variety of species/strains, duration of use, and dosages with several different intended purposes (Table ). The effects of probiotics are strain specific, and therefore, strain identity is important to link to a specific health effect as well as to enable accurate surveillance and epidemiological studies. Unfortunately, government regulatory organizations are highly varied across national borders and jurisdictions in regulation of probiotics, making uniform recommendations difficult.
In 2001, the FAO/WHO held the Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics, to develop standardized guidelines for evaluating probiotics in food that could lead to the substantiation of health claims [Citation226]. The proposed guidelines recommend: 1) identifying of the genus and species of the probiotic strain by using a combination of phenotypic and genotypic tests as clinical evidence suggesting that the health benefits of probiotics may be strain specific, 2) in vitro testing to delineate the mechanism of the probiotic effect, and 3) substantiating the clinical health benefit of probiotic agents with human trials. Additionally, safety assessment of the probiotic strain should at a minimum determine: 1) patterns of antimicrobial drug resistance, 2) metabolic activities, 3) side effects noted in humans during clinical trials and after marketing, 4) toxin production and hemolytic potential if the probiotic strain is known to possess those properties, and 5) lack of infectivity in animal studies [Citation226].
The regulation of probiotics differs between countries as there is no universally agreed framework. For the most part, probiotics are categorized as food and dietary supplements because most are delivered by mouth as a food or supplement. For example, Health Canada has provided a Natural Health Product monograph that includes dosage form(s), use(s) or purpose(s) recommended as well as minimum quantities for L. johnsonii (La1/Lj1/NCC 533, an adjunct to physician-supervised antibiotic therapy in patients with H. pylori infections, 1.25 × 108 CFU) (all strains, 1 × 107 CFU), L. rhamnosus (GG, Management of acute infectious diarrhea, 6 × 109 CFU, management/risk reduction of antibiotic-associated diarrhea, 1 × 1010 CFU) (all strains, 1 × 107 CFU), and S. boulardii / S. cerevisiae (all strains, Risk reduction of antibiotic-associated diarrhea, 1 × 1010 CFU) (all strains, 1 × 107 CFU). The probiotic product monograph contains both bacteria and fungi which have been pre-approved for the use or purpose which allows claims; “source of probiotics”, “helps support intestinal/gastrointestinal health”, “could promote a favorable gut flora” with 1 × 107 CFU daily. The minimum daily dose is the sum of CFU per day provided by all live microorganisms that are present in the product, and not the minimum amount of CFU per day for each of the microorganisms. Further, a duration of use statement is not required, nor is there any guidance provided. Cautions include; “If you have fever, vomiting, bloody diarrhea, or severe abdominal pain, consult a health care practitioner prior to use” and “If symptoms of digestive disorders (e.g., diarrhea) occur, worsen and / or persist beyond 3 days, discontinue use and consult a health care practitioner.” [Citation227]. In Canada, probiotics have two modes of sale on the market, Natural and Non-Prescription Health Products Directorate (NNHPD) and Food Directorate [Citation3, Citation228]. Health Canada uses a pre-market approval process for non-food like applications such as capsules, tablets, softgels and powders which requires companies to acquire a Natural Product Number (NPN) prior to bringing to market [Citation3]. Table below details the current licensed products and claims specific to sport performance using probiotic strain(s) in or outside the pre-approved monograph. This list is open access through the Health Canada LCNHPD (Licensed Natural Health Products Database) which allows consumers and retailers the ability to review claims on packaging to approved claims by the NNHPD [Citation229].
Japan is viewed by many to be a global market leader given that probiotics are available as both foods and drugs [Citation230], and was the first global jurisdiction to implement a regulatory system for functional foods and nutraceuticals in 1991. Under Japanese regulations, probiotic products are in a distinct category of foods known as Foods for Specific Health Uses (FOSHU). For probiotic food products, efficacy claims are prohibited on the labeling. If claims are to be made about efficacy, one must obtain special permission from the Ministry of Health and Welfare (MHLW) for the product to be considered FOSHU, for which substantiation of efficacy and safety is a mandatory requirement [Citation231]. In Brazil, probiotics are considered as functional foods, and considered to be different from food. But legislation asks for safety and efficacy demonstration of food products and hence all these products must be registered and approved by a health authority called National Health Surveillance Agency Brazil (ANVISA) [Citation230].
In the European Union, probiotics and food supplements are regulated under the Food Products Directive and Regulation (regulation 178/2002/EC; directive 2000/13/EU). All health claims for probiotics have to be authorized by EFSA which has issued a list of microbial cultures that have a Qualified Presumption of Safety [Citation232], meaning that they do not require safety assessments. The EFSA is also responsible for assessing health claims made for probiotic products. So far, EFSA has rejected all submitted health claims for probiotics. While rigorous scrutiny of product claims is apparent, there appears to be little regulation of the manufacturing process and almost no post-marketing regulatory follow-up [Citation233].
In the United States, government regulation of probiotics is complex. Depending on a probiotic product’s intended use, the FDA might regulate it as a dietary supplement, a food ingredient, or a drug. Many probiotics are sold as dietary supplements, which do not require FDA approval before they are marketed. Dietary supplement labels are permitted to make claims about how the product affects the structure or function of the body without FDA approval, but they cannot make health claims (claims that the product reduces the risk of a disease) without the FDA’s approval [Citation234]. Further, dietary supplements are required to comply with Good Manufacturing Practice guidelines, but these do not extend to testing quality or efficacy [Citation233]. From the examples provided, it is apparent that the current approach to regulation is inadequate and can lead to problems of quality, safety, and claim validity in commercial probiotic products used in a medical context, including those used in vulnerable populations [Citation233].
In January 2017, the Council for Responsible Nutrition (CRN) and the International Probiotics Association (IPA) announced the development of scientifically-based best practices manufacturing guidelines for the labeling, storing, and stability testing of dietary supplements and functional foods containing probiotics [Citation235]. These guidelines were designed to facilitate transparency and consistency in the probiotic sector. A key element of the guidelines is labelling probiotic products in CFU, the scientifically accepted unit of measure for probiotics and used to report probiotic quantity in many studies conducted to assess the safety or benefits of probiotics. Consistent with scientific literature, CFU are commonly used on probiotic product labels in many jurisdictions around the world to help consumers and healthcare professionals identify products providing probiotics in amounts shown to have benefit. However, United States regulations require dietary ingredients (with the exception of some vitamins) be labeled by weight. Labeling probiotic quantity by weight is not meaningful because this measure does not indicate the viability of the microorganisms in the product throughout shelf life. To the contrary, CFU are more representative of the quantity of viable microorganisms and gives consumers and healthcare professionals accurate information. The FDA has recently agreed that in addition to weight, probiotic amounts can also be labelled in CFU.
Upon examining the relevant literature investigating the effects of probiotic supplementation on athletes and those physically active, the genera commonly used included Lactobacillus (n = 35), Bifidobacterium (n = 18), Streptococcus (n = 8) and Bacillus (n = 5) (Table ). In addition, several studies used a combination of species and strains (n = 17), ranging from two up to 14 different species/strains. The dose of probiotic administered is an important factor to be considered. In two reviews related to dietary supplementation in athletes, dosing regimens were reported in the range between 1 × 109 to 4 × 1010 CFU [Citation10, Citation40]. In a 2018 consensus statement, the International Olympic Committee noted moderate support for probiotic use in athletes with a daily dose of 1 × 1010 live bacteria [Citation5]. In our review, we report a wide range of doses (Table ), and in several studies the dosage was not reported.
Similar to the type of probiotic used, the duration of supplementation has also been variable in the studies reviewed (Table ). The shortest duration lasted 7 days [Citation75, Citation76] and the longest lasted 150 days [Citation68]. The duration and consistency of probiotic supplementation are important factors. Coqueiro et al. [Citation188] noted that in clinical practice probiotic supplementation should be implemented for at least 14 days prior to competition or important events for the athlete. Therefore, studies that supplement for a similar or shorter period should be evaluated with caution. With the interruption of probiotic intake, there is a reduction in the microorganism administered in the colon, and with 8 days of supplementation discontinuation, the probiotic is no longer detectable in the gut [Citation236]. Finally, there is some limited evidence that discrepancies exist between males and females, even after supplementation of probiotics with the same dose [Citation61]. Future studies are needed in this area, with the intention of establishing a recommendation for each sex.
Future directions
Overall, the effects of probiotics in athletes have received less attention compared to animal studies and human clinical conditions in the general population. A PubMed search conducted in October 2019 yielded the following listings for various combinations of key terms: probiotic and athlete, n = 145; probiotic and rodent, n = 3407; probiotic and diabetes, n = 844; probiotic and child, n = 2930; probiotic and elderly, n = 2257. Clearly, the focus of the research community has been investigating the beneficial effects of probiotics on gut and immune health in various subgroups of the general population. In animals, probiotics have been associated with benefits including normalizing age-related drops in testosterone levels [Citation237], increasing neurotransmitter synthesis [Citation238], reducing stress-induced cortisol levels [Citation239], reducing inflammation [Citation100] and improving mood [Citation240]. However, all these potential benefits lack current substantiation in human intervention trials in an athletic population. Here we discuss future research opportunities to explore in relation to the microbiome and athletes.
Body composition and muscle mass
It is well known that to increase levels of muscle mass, resistance training must be included in exercise regimens. Probiotic supplementation, both with and without resistance training, can decrease levels of body weight and fat mass in overweight and obese individuals, as well as female athletes [Citation103, Citation241, Citation242]. Increases in fat free mass, however, have only been shown in animal models. Chen and colleagues [Citation92] supplemented male Institute of Cancer Research (ICR) strain mice with L. plantarum TWK10 for 6 weeks. Mice were divided into three groups and daily doses of 0, 2.05 × 108, or 1.03 × 109 CFU were given to each group, respectively. The dosages chosen were modified from a comparable human dose equivalent to mouse body size. Relative muscle weight (%), as measured by combining the gastrocnemius and soleus muscles, were significantly increased in mice consuming the probiotic compared to placebo. Additionally, the number of type I fibers were increased significantly.
Mechanistically, it is plausible that Lactobacillus strains decrease levels of inflammation, thereby decreasing activation of intracellular proteins linked to muscle atrophy, which may eventually link to an observed increase in muscle mass. Chen et al. [Citation92] also determined that probiotic supplementation increased forelimb grip strength and swim-to-exhaustion performance in mice, which may or may not have been related to improvement in muscle mass. Though improvements in body composition have been shown in humans, more studies examining decreased inflammation as a mechanism to increase muscle mass, in conjunction with reduction in fat mass, is warranted.
Buffering capacity in exercising muscles
Physiological fatigue, such as extreme fatigue after exercise, is accompanied by poor athletic performance and loss of favorable working conditions for tissues [Citation243]. In response to higher intensity exercise, the concentration of lactate and hydrogen ions increased markedly resulting in an acidification in muscle and subsequent fatigue [Citation244, Citation245]. Approximately 75% of the total amount of lactate produced is used for oxidative production of energy in the exercising body and can be utilized for the de novo synthesis of glucose in the liver [Citation246].
Probiotic supplementation may have potential to remove and utilize blood lactate after exercise. For instance, most Lactobacillus species produce lactic acid, which could facilitate the production of butyrate by lactate-utilizing bacteria that first produce acetyl-CoA from lactate [Citation247]. In the classical pathway, the enzymes phosphotransbutyrylase and butyrate kinase convert butyryl-CoA to butyrate and coenzyme A with concomitant formation of ATP. Thus, probiotics and the gut microbiota could play important roles in maintaining normal physiology and energy production during exercise. Several animal studies have been conducted with promising results. In mice who consumed a probiotic kefir daily over 4 weeks, swimming time-to-exhaustion was significantly longer, forelimb grip strength was higher and serum lactate, ammonia, blood urea nitrogen (BUN), and creatine kinase levels were lower after the swimming test [Citation248]. In mice supplemented with L. plantarum TWK10 over 6 weeks, supplementation dose-dependently increased grip strength and endurance swimming time and decreased levels of serum lactate, ammonia, creatine kinase, and glucose after an acute exercise challenge [Citation92]. Furthermore, the number of type I fibers in gastrocnemius muscle significantly increased with LP10 treatment. In a six-week human double-blind placebo-controlled clinical study, young healthy amateur runners supplemented with L. plantarum TWK10 and underwent an exhaustive treadmill exercise measurements and related biochemical indexes [Citation85]. The TWK10 group had significantly higher endurance performance and glucose content in a maximal treadmill running test compared to the placebo group (P < 0.05), indicating that TWK10 supplementation may be beneficial to energy harvest. Together, these studies suggest a role in which certain probiotics may enhance energy harvesting, and have health-promotion, performance-improvement, and anti-fatigue effects. These are areas that may warrant further research consideration.
Considerations for future study designs
Several important methodological shortcomings in research design should be addressed to improve scientific evidence for the biological and clinical benefits of probiotics. For example, discrepancies between men and women, even after supplementation of probiotics with the same dose, are evident [Citation61]. In this sense, in studies with both sexes, conflicting results may occur. In many instances and products, the recommendation for probiotic supplementation is no different for men and women, necessitating studies investigating this topic, with the intention of establishing a recommendation for each sex.
Other design concerns include the relatively small number of subjects, which may compromise the accuracy and interpretation of results. The period of supplementation is another important factor as the time of adaptation of the organism to the probiotic is approximately 14 days. Thus, studies that supplement for a similar or shorter period should be evaluated with caution. Further, with the interruption of probiotic intake, there is a reduction in the microorganism administered in the colon, and with 8 days of supplementation discontinuation, the probiotic is no longer detectable in the gut [Citation236]. In clinical practice, it is common sense that probiotic supplementation should be implemented for at least 14 days prior to competition or important events for the athlete, given that during this period the GI tract adapts to the administered microorganism [Citation188], and there may be mild, transient GI symptoms, such as flatulence [Citation10]. The long-term effects of probiotic administration in athletes over several months or years on gut health, immune function and rates of illness are unclear, as in most studies the supplementation period was between 4 to 16 weeks.
Since many effects are dose-dependent, the amount of probiotic administered is an important factor to be considered. The range of oral probiotic supplementation is, approximately, 108–109 CFU per day, however, this value varies in each country [Citation249, Citation250] and notably, no specific probiotic recommendation has been established for athletes or physical activity practitioners. Most of the studies do not control for previous levels of physical activity, so individuals within the same study may have very different levels of physical activity, making comparisons unrealistic. Finally, very few studies have evaluated the performance in strength exercises after supplementation with probiotics and this is an important area of sports and physical training to be studied.
Hormonal balance
Oral supplementation with selective bacteria holds promise in positively affecting the endocrine system. In mice, the microbiota can regulate testicular development and function [Citation251], while androgen deficiency has substantially altered the microbiome [Citation252]. Supplementation with a selenium-enriched probiotic in conjunction with a high-fat diet in male mice significantly alleviated the adverse effects of hyperlipidemia by reducing testicular tissue injury, increasing serum testosterone levels, and improving sperm indexes [Citation253]. Further, aging mice supplemented with the probiotic bacterium L. reuteri had larger testicles and increased serum testosterone levels compared to their age-matched controls [Citation237, Citation254].
In a human pilot study, supplementation with L. acidophilus and B. longum (1 × 109 CFU) did not alter plasma hormones, including testosterone, dihydrotestosterone, androstenedione, dehydroepiandrosterone sulfate, and sex hormone-binding globulin, in 31 healthy males (18 to 37 years old) over a two-month period [Citation255]. However, another pilot study supplementing a probiotic and prebiotic (L. paracasei B21060 5 × 109 cells + arabinogalactan 1243 mg + fructooligosaccharides 700 mg + L-glutamine 500 mg) over 6 months in infertile male patients improved gonadal pathway function including increased follicle stimulating hormone, luteinizing hormone, and testosterone levels compared to a control group [Citation256].
Interestingly, Tremellen et al. [Citation257] proposed that gut-derived endotoxin can reduce gonadal function in obese males. Obesity and a high fat/high calorie diet can alter gut bacteria and intestinal wall permeability, leading to the passage of LPS from within the gut lumen into the circulation (metabolic endotoxemia), where it initiates systemic inflammation [Citation258]. Endotoxin can reduce testosterone production by the testes, both by direct inhibition of Leydig cell steroidogenic pathways and indirectly by reducing pituitary luteinizing hormone drive and sperm production [Citation259]. Tremellen and colleagues [Citation257] theorized the male reproductive axis has evolved the capacity to lower testosterone production during times of infection and resulting endotoxin exposure, decreasing the immunosuppressive influence of testosterone, in turn enhancing the ability to fight infection. Weight loss and physical activity seem to improve these symptoms [Citation260]. These novel findings suggest a potential impact for microbe therapy in obese and/or aging athletes by imparting hormonal and gonadal features of reproductive fitness typical of much younger healthy individuals. However, studies are severely lacking. In the future, larger sample sizes and more robust study designs will be needed.
Inactivated “probiotics”
There is an increasing interest in supplementation with non-viable microorganisms or microbial cell extracts. By definition, probiotics are required to be alive, therefore inactivated microorganisms cannot be classified as such. However, preparations from certain probiotic species and strains (such as those from lactobacilli and bifidobacteria) have shown to maintain health benefits even after no longer being viable [Citation261–Citation263]. Inactivation can be achieved by different methods, including heat, chemicals (e.g., formalin), gamma or ultraviolet rays, and sonication, with heat treatment being the method of choice in most cases [Citation228, Citation264, Citation265]. Importantly, these methods of inactivation may affect structural components of the cell differently, and therefore their biological activities [Citation264, Citation265]. Piqué et al. (2019) suggested the presence of key structures in the cell or supernatant fractions may confer probiotic properties, mainly through immune-modulation, protection against pathogens, and fortifying the mucosal barrier integrity [Citation261]. These different bacterial components include lipoteichoic acids, peptidoglycans, and/or exopolysaccharides [Citation261].
Favorable properties of heat-killed bacteria have been observed in vitro [Citation266], in animal models [Citation264], and human trials [Citation267, Citation268]. For example, in healthy subjects with high levels of self-reported psychological stress, supplementation with heat-killed L. plantarum L-137 significantly lowered incidence of URTI after 12 weeks compared to the control group [Citation269]. This finding may have resulted from innate immunity stimulation as heat-killed L. plantarum L-137 has been reported to enhance type I IFN production in humans [Citation270]. In athletes, there have only been two studies published examining the effect of these inactivated “probiotics”. In a randomized, double blind, placebo-controlled trial, 51 male athletes engaged in high intensity exercise (> 11 h per week) and consumed a placebo or heat-killed L. lactis JCM 5805 daily for 13 days [Citation262]. Compared to placebo, supplementation increased the maturation marker of plasmacytoid DC pDC (CD86), responsible for the antiviral response, and decreased the cumulative days of URTI symptoms. Furthermore, ingestion decreased cumulative days of self-reported fatigue. In a longer duration randomized, double blind, placebo-controlled study, 49 long-distance runners consumed heat-inactivated L. gasseri CP2305 or placebo daily for 12 weeks [Citation271]. No significant difference in physical performance between the CP2305 and placebo group were detected. However, CP2305 supplementation improved recovery from fatigue and relieved anxiety and depressive mood compared with placebo intake. Further, CP2305 intake prevented training-induced reduction of hemoglobin and facilitated exercise-induced increase in serum growth hormone levels. Moreover, gene expression profiling of peripheral blood leukocytes indicated that CP2305 prevented the stress-induced changes in the expression of genes related to mitochondrial functions. In relation to the gut microbiota, CP2305 intake increased the alpha- and beta-diversity, and the compositions of Bifidobacterium and Faecalibacterium. These compositional changes in the gut microbiota may have contributed to the recovery of fatigue and moderation of stress and anxiety through the gut-brain axis. Indeed, inactivated CP2305 can relieve stress in healthy young adults facing stressful conditions [Citation272]. While encouraging, it is unclear how the daily intake of the heat-inactivated probiotics could affect the gut-brain axis and alter stress responses. Further research investigating potential mechanisms as well as more extensive studies with a wider range of athletes and exercise loads should be conducted. In addition, primary aims related to GI tract health and exercise performance should be more thoroughly assessed.
Mood and cognition
Physical health and mental health are strongly linked with depression, which is recognized as a leading cause of disability throughout the world [Citation273]. Recently, it has been reported that 35% of individuals with depression also have symptoms of a leaky gut [Citation274], which strengthens the notion of a link between the brain and the GI tract. As reported by Clarke et al. [Citation275], gut bacteria contribute to various mood states in an individual. The gut-brain axis is a bidirectional pathway via the neural, endocrine, and immune systems. The mechanisms by which probiotics improve symptoms of depression and other mood disorders are via anti-inflammatory actions that reduce activity of the hypothalamic-pituitary-adrenal (HPA) axis [Citation276].
Probiotics may be an effective treatment strategy for depression and mood disorders such as anxiety given the link between GI tract bacteria and the brain (i.e. the gut-brain axis), as decreased intestinal dysbiosis may have beneficial effects on mood. Only a few studies have been completed in human subjects that have examined the impact of probiotic supplementation on mood and anxiety. Benton and colleagues [Citation210] reported that 3 weeks of supplementation with 1 × 108 CFU of L. casei had positive effects on mood, with subjects feeling increased clear-headedness, confidence, and elation compared to baseline. A study by Rao et al. [Citation277], reported that 8 weeks of 8 × 107 CFU of L. casei given to individuals with chronic fatigue syndrome reduced anxiety symptoms. Similarly, Messaoudi and others [Citation278] found decreased anxiety related behaviors after 2 weeks of a combination of L. helveticus and B. longum in 25 healthy adults. Moreover, 6 weeks supplementation of 4 × 109 CFU/live cells of L. fermementum LF16, L. rhamnosus LR06, L. plantarum LP01, and B. longum BL04 improved mood and sleep quality with a reduction in depressive mood state, anger and fatigue [Citation279].
Overall, research on probiotics and mood in athletic populations is lacking. One review, completed by Clark and Mach [Citation280] likened the psychological demands of exercise to physical stress. These authors concluded that the gut microbiota acts as an endocrine organ, secreting neurotransmitters such as serotonin and dopamine, thereby controlling the hypothalamic-pituitary axis in athletes. It is unclear whether these conclusions are attributable to the physiological or psychological stress, and more research is needed to expand on the current findings.
Muscle damage and recovery
Inflammation has been implicated in probiotic supplementation impacting body fat levels in overweight and obese individuals, as well as athletic populations. Research in this area, however, has been completed entirely in animal models. Zhao et al. [Citation281] reported that supplementation of Akkermancia muciniphila in lean mice fed a chow diet for 5 weeks significantly improved markers of low-grade, chronic inflammation via measurement of LPS, and alleviated gains in both body weight and fat mass. Probiotic supplementation also increased anti-inflammatory factors α-tocopherol and β-sitosterol. Interaction between A. muciniphila and inflammatory processes may subsequently impact metabolic health and consequently body composition regulation. In humans, low-grade, chronic inflammation is a marker of many disease states and aspects of the metabolic syndrome. To date, no such research has been completed in athletic populations to clarify the impact of probiotic supplementation on body composition in athletes.
Neurotransmitter synthesis and release
Choline and its derivatives serve as components of structural lipoproteins, blood and membrane lipids, and as a precursor of the neurotransmitter, acetylcholine [Citation282]. Choline is converted into acetylcholine via the enzyme choline acetyltransferase. Increasing plasma levels of choline could improve the production of acetylcholine, increase muscular contraction, and possibly delay fatigue in endurance exercise [Citation282]. Elevated choline levels were observed in plasma of mice supplemented with L. rhamnosus compared to those fed with L. paracasei and controls [Citation283]. In humans, probiotics and choline have been studied in the context of Trimethylamine N-oxide (TMAO). TMAO is an atherogenic metabolite that requires gut microbes for its generation through a metaorganismal pathway that begins with dietary consumption of trimethylamine (TMA) containing precursors such as choline, carnitine and phosphatidylcholine [Citation284]. In a two-week clinical study on 19 healthy, non-obese males, supplementing with a multi-strain probiotic following a hypercaloric, high-fat diet failed to elevate plasma choline levels [Citation285]. In a three-month pilot study investigating the effects of probiotic supplementation on TMAO plasma levels in hemodialysis patients, choline did not change compared to control group [Citation286]. There is currently no research in athletes or active individuals, yet increases in plasma choline could (in theory) support increases in acetylcholine and consequently power, and endurance.
Nutrient timing
As indicated previously, various supplementation protocols have been implemented regarding probiotic consumption supplementation, including taking on an empty stomach, with food, and even after exercise. In relation, little is known pertaining to the optimal timing of probiotic intake for improved microbial survival and nutrient absorption. Tompkins et al. utilized an in vitro digestive model of the upper GI tract to investigate the timing effects of probiotic intake utilizing a multi-species encapsulated product containing L. helveticus R0052, L. rhamnosus R0011, B. longum R0175, and S. cerevisiae boulardii [Citation287]. Results of this investigation showed that when a probiotic was consumed 30 min before a meal or with a meal, the bacteria survived in high numbers. Conversely, when the probiotic was taken 30 min after a meal, the bacteria did not survive in high numbers. Additionally, this study reported that consumption of the probiotic with 1% milk and oatmeal-milk gruel allowed for higher bacteria survival than when consumed with apple juice or spring water. Thus, future work should focus on the most favorable time to consume probiotics to promote survival in humans along with optimal nutrient/foodstuffs co-ingestion.
Response to a physical or mental stressor
Cortisol is a steroid hormone released by the adrenal glands in response to stress and increased levels have been related to suppression of the immune system in athletes [Citation288–Citation290]. Moreover, a connection has been established between the digestive tract and stress [Citation291, Citation292]. Several studies that supplemented healthy young college students during exam preparation with probiotics (L. plantarum 299v and L. casei Shirota) reported attenuation of cortisol compared to a control group [Citation293–Citation295]. However, in an eight-week crossover design, 29 healthy male volunteers who supplemented with L. rhamnosus exhibited little difference in stress-related measures, HPA axis response, inflammation, or cognitive performance in comparison to placebo [Citation296]. More recently, a systematic review and meta-analysis of clinical and pre-clinical literature on the effects of probiotics on anxiety asserted that probiotics may help reduce anxiety [Citation297]. However, these findings have not yet been fully translated in clinical research in humans. More relevant to performance, eight endurance-trained males in a blinded randomized crossover design who supplemented with a probiotic beverage (L. casei, 1 × 1011 CFU) for seven consecutive days before a two-hour running exercise at 60% VO2max in hot ambient conditions (34.0 °C and 32% RH) failed to exhibit a decrease in cortisol response compared to a placebo [Citation75].
Summary
Understanding whether probiotic supplementation plays a role in athletic performance is of interest to athletes who work to improve their training and competition performance. Moreover, this knowledge may be of general benefit to human health. Further studies are required to understand how the microbiome influences anti-inflammatory effects, optimal breakdown and utilization of consumed food, and other beneficial effects for overall health in athletes. Overall, the studies reviewed in this position statement provide modest evidence that probiotics can provide some clinical benefits in athletes and other highly active individuals (Table ). The difficulty in interpreting the studies is illustrated by variations in clinical outcome measures and most importantly, as probiotic benefits are strain-specific, by different strains used in these studies.
As outlined in Table , the following probiotic strains/species have been linked to an increase in athletic performance and/or recovery:
B. coagulans GBI-30, 6086 (BC30) at 1 × 109 CFU has beneficial effects in combination with protein on exercise recovery;
Encapsulated B. breve BR03 in combination with S. thermophilus FP4 at 5 × 109 CFU each has beneficial effects on exercise recovery and performance following muscle-damaging exercise;
L. delbrueckii ssp. bulgaricus at 1 × 105 CFU can increase VO2max and aerobic power;
L. acidophilus SPP, L. delbrueckii bulgaricus, B. bifidum, and S. salivarus thermophilus at 4 × 1010 CFU administered in form of a yogurt drink can increase VO2max;
L. plantarum TWK10 at 1 × 1010 CFU has been shown to increase endurance performance;
L. acidophilus, L. rhamnosus, L. casei, L. plantarum, L. fermentum, B. lactis, B. breve, B. bifidum and S. thermophilus at 4.5 × 1010 CFU can increase run time to fatigue in the heat.
The following probiotic strains/species have been linked to improved gut health in athletes (see Table ):
L. rhamnosus GG at 4 × 1010 CFU in form of a milk-based drink,
B. bifidum W23, B. lactis W51, E. faecium W54, L. acidophilus W22, L. brevis W63, and L. lactis W58, at 1 × 1010 CFU;
L. salivarius (UCC118) (unknown dose).
The following strains/species have been shown to improve immune health in athletes, reducing the episodes, severity or duration of exercise-induced infections:
1.2 × 1010 CFU L. fermentum VRI-003 (PCC) at 1.2 × 1010 CFU and at 1 × 109 CFU in males;
L. casei Shirota (LcS) at 6.5 × 109 CFU twice daily;
L. delbrueckii bulgaricus, B. bifidum, and S. salivarus thermophilus at 4 × 1010 CFU administered in the form of a yogurt drink;
B. animalis subsp. lactis BI-04 2 × 1010 CFU;
L. gasseri 2.6 × 109 CFU, B. bifidum 0.2 × 109, and B. longum 0.2 × 109 CFU;
B. bifidum W23, B. lactis W51, E. faecium W54, L. acidophilus W22, L. brevis W63, L. lactis W58 at 1 × 1010 CFU;
L. helveticus Lafti L10 at 2 × 1010 CFU.
Given the small number of studies, and substantial variation in experimental approaches, dependent measures, and outcomes, more well-designed studies of probiotic supplementation in various athlete groups are warranted. While a majority of probiotics currently on the market, and tested in humans, feature the Lactobacillus, Bifidobacterium, and Bacillus genera, new microbiome research and technological advances are identifying potential next-generation probiotic candidates. Further research is needed not only to identify these discoveries, and validate their performance and recovery benefits in clinical settings.
Recommendations
Athletes and physically active individuals should thoroughly review health care and consumer information on specific applications, dosage, and possible contraindications of probiotic supplementation. As with any dietary supplementation, probiotics should be considered in the overall context of balanced dietary intake, i.e. nutrient needs should be met by a “food first” approach via consumption of whole foods rather than supplements. For example, recommending dietary supplements to developing athletes might overemphasize their importance in comparison to other training and dietary strategies [Citation298]. In this context, it is also important to remember that some food-based probiotic products (e.g. yogurt) contain energy, carbohydrate, protein, and other nutrients that can form part of an athlete’s overall nutrition plan. Only reputable sources of commercially available supplements should be used to reduce the risk of contaminants that might contravene doping in sport regulations [Citation5]. Athletes should be educated on the likely risks of contamination given that the World Anti-Doping Agency enforces a principle of strict liability for positive test results involving banned substances. Different formulations of probiotics from tablets or capsules to powder (added to drinks) or probiotic-enriched chewable tablets are available to meet individual preferences.
Probiotic supplements should be packaged, stored, handled, and transported in an appropriate manner. Athletes should take particular care in warm to hot environments and avoid, where possible, leaving supplements outdoors for long periods in direct sunlight, in a motor vehicle, or near an oven or other heat-generating appliances. New technology has led to probiotic supplements that do not require refrigeration, which may be ideal for athletes during travel. Supplements should also be kept dry at all times. During travel it might be useful for individuals to keep probiotics with other nutritional supplies, supplements, ergogenic acids or medications, or held by team personnel as required.
In terms of implementation, probiotic supplementation should commence at least 14 days before a major training period or competition to allow adequate time for transient colonization or adaptation period of bacterial species in the gut. Another important issue is the increased risk of GI problems during travel [Citation299]. Supplementation with probiotics for individuals and athletes traveling could be included in an overall illness prevention plan. Tolerance and side effects should be monitored by the athlete, coach, and support staff and a medical opinion sought if there is ongoing concern. It is not unusual to experience transient increased activity in the gut during the colonization period (e.g., intestinal rumbling, increased flatulence, etc.) and athletes should be informed that mild side effects for a few days are not uncommon [Citation61]. Athletes should be encouraged to review and monitor probiotic consumption on a daily basis to promote compliance and best practice usage. Compliance might be improved by having athletes take the probiotic supplement at the same time each day (e.g., at breakfast). Probiotic supplementation should be tested during the offseason or preseason phases, so the athlete is familiar with taking the probiotic supplements or foods before travel or major competition, and can see how he/she responds. This practice is also useful in the context of assessing individual tolerance and potential adverse effects.
Position of the International Society of Sports Nutrition (ISSN)
After reviewing the scientific and medical literature in this area, the International Society of Sports Nutrition concludes the following in terms of probiotic supplementation as the official Position of the Society:
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host (FAO/WHO).
Probiotic administration has been linked to a multitude of health benefits, with gut and immune health being the most researched applications.
Despite the existence of shared, core mechanisms for probiotic function, health benefits of probiotics are strain- and dose-dependent.
Athletes have varying gut microbiota compositions that appear to reflect the activity level of the host in comparison to sedentary people, with the differences linked primarily to the volume of exercise and amount of protein consumption. Whether differences in gut microbiota composition affect probiotic efficacy is unknown.
The main function of the gut is to digest food and absorb nutrients. In athletic populations, certain probiotics strains can increase absorption of key nutrients such as amino acids from protein, and affect the pharmacology and physiological properties of multiple food components.
Immune depression in athletes worsens with excessive training load, psychological stress, disturbed sleep, and environmental extremes, all of which can contribute to an increased risk of respiratory tract infections. In certain situations, including exposure to crowds, foreign travel and poor hygiene at home, and training or competition venues, athletes’ exposure to pathogens may be elevated leading to increased rates of infections. Approximately 70% of the immune system is located in the gut and probiotic supplementation has been shown to promote a healthy immune response. In an athletic population, specific probiotic strains can reduce the number of episodes, severity and duration of upper respiratory tract infections.
Intense, prolonged exercise, especially in the heat, has been shown to increase gut permeability which potentially can result in systemic toxemia. Specific probiotic strains can improve the integrity of the gut-barrier function in athletes.
Administration of selected anti-inflammatory probiotic strains have been linked to improved recovery from muscle-damaging exercise.
The minimal effective dose and method of administration (potency per serving, single vs. split dose, delivery form) of a specific probiotic strain depends on validation studies for this particular strain. Products that contain probiotics must include the genus, species, and strain of each live microorganism on its label as well as the total estimated quantity of each probiotic strain at the end of the product’s shelf life, as measured by colony forming units (CFU) or live cells.
Preclinical and early human research has shown potential probiotic benefits relevant to an athletic population that include improved body composition and lean body mass, normalizing age-related declines in testosterone levels, reductions in cortisol levels indicating improved responses to a physical or mental stressor, reduction of exercise-induced lactate, and increased neurotransmitter synthesis, cognition and mood. However, these potential benefits require validation in more rigorous human studies and in an athletic population.
Conclusion
Given all the known benefits and favorable safety profile of probiotic supplementation reported in the scientific and medical literature, probiotics are commonly used to optimize the health of athletes. Regular consumption of specific probiotic strains may assist with immune function and may reduce the number of sick days an athlete experiences when training or during competition. Certain probiotic strains may reduce the severity of respiratory infection and GI disturbance when they occur. Probiotic benefits are strain specific and dose dependent, and include improved gut-barrier function, nutrient absorption, recovery and performance in athletes. When choosing a probiotic product, athletes are encouraged to use clinically researched strains with validated benefits, matching the athletes desired health benefit. Studies investigating the effects of probiotics in athletic populations and on sports performance are limited and warrant further investigation.
Author contributions
RJ, AEM, KCC, CMK prepared and compiled the draft for review and editing by coauthors. All other co-authors reviewed, edited, and approved the draft, and the final manuscript.
Ethics approval and consent to participate
This paper was reviewed by the International Society of Sports Nutrition Research Committee and represents the official position of the Society.
Consent for publication
Not applicable.
Competing interests
AM, ASR, KB, LB, and SDW declare no competing interests. RJ has received grants to evaluate the efficacy and safety of probiotics, serves on scientific advisory boards, and has served as an expert witness, legal and scientific consultant. AEM and KCC are employed by Isagenix, a company selling branded probiotics products. CMK has previously received external funding to conduct research studies involving nutritional supplements and is currently conducting studies involving prebiotics and probiotics. MP has received grants to evaluate the efficacy and safety of probiotics, and has served as a scientific consultant. JRT reports no conflicts of interest regarding the material or paper presented. JRT has previously received grants to evaluate the efficacy of various nutritional supplements including probiotics. ML conducts industry sponsored studies and serves as a scientific consultant to the Juice Plus+ Company. MG reports no conflicts of interest regarding the material or paper presented. MG has previously received external funding to conduct research studies involving nutritional supplements including probiotics. DBP reports no conflicts of interest regarding the material or paper presented, and has received grants to evaluate the effectiveness of probiotic supplementation in athletes. BIC serves on the scientific advisory board of Dymatize (Post Holdings). SMA reports no conflicts of interest related to the material presented in this paper. He has conducted industry sponsored studies at the universities he has been affiliated with and has occasionally served as an expert witness and scientific consultant. RBK reports no conflicts of interest related to the material presented in this paper. He has conducted industry sponsored studies at the universities he has been affiliated with and occasionally serves as a scientific and legal consultant related to exercise and nutrition intervention studies. CJW is employed by Jamieson Labs, a company selling branded probiotics products. MPa is employed by Biolab research Srl, performing research & development activities for Probiotical SpA, a leading probiotic supplier. DSK works for a Contract Research Organization (Nutrasource) that has received funding from the probiotic industry for clinical trials and serves on the Scientific Advisory Board for Dymatize (Post Holdings). JS is a co-founder of FitBiomics, a company identifying, researching and commercializing new probiotic strains. JAT is employed by the International Probiotic Association and further consults within the probiotic and microbiome industries. JA is the CEO of the International Society of Sports Nutrition.
Abbreviations
AE | = | Adverse events |
ANVISA | = | National Health Surveillance Agency Brazil |
ATP | = | Adenosine triphosphate |
BCAAs | = | Branched-chain amino acids |
BMI | = | Body mass index |
BUN | = | Blood urea nitrogen |
CD14 | = | Cluster of differentiation factor-14 |
CFU | = | Colony forming units |
CLA | = | Conjugated linoleic acid |
CLR | = | C-type lectin receptor |
CRN | = | Council for Responsible Nutrition |
CRP | = | C-Reactive protein |
EFSA | = | European Food Safety Authority |
FAO | = | Food and Agricultural Organization |
FDA | = | Food and Drug Administration |
FOSHU | = | Foods for Specific Health Uses |
GI | = | Gastrointestinal |
GPR | = | G-Protein couple receptor |
HIV | = | Human immunodeficiency virus |
HPA | = | Hypothalamic-pituitary-adrenal axis |
IBD | = | Inflammatory bowel disease |
ICR | = | Institute of Cancer Research |
IgA | = | Immunoglobulin A |
IL-1β | = | Interleukin-1beta |
IL-6 | = | Interleukin-6 |
IOC | = | International Olympic Committee |
IPA | = | International Probiotic Association |
ISSN | = | International Society of Sports Nutrition |
LPS | = | Lipopolysaccharide |
MHLW | = | Ministry of Health and Welfare |
NK-κβ | = | Nuclear factor kappa beta |
NOD | = | Nucleotide-binding oligomerization domain |
PAG | = | Phenylacetylglutamine |
PAMP | = | Pathogen associated molecular pattern |
PCR | = | Polymerase chain reaction |
PPR | = | Pattern recognition receptors |
RNA Seq | = | RNA sequencing |
SFCA | = | Short chain fatty acid |
TLR | = | Toll-like receptor |
TMAO | = | Trimethylamine N-oxide |
TNF-α | = | Tumor necrosis factor-alpha |
Treg | = | Regulatory T cells |
URTI | = | Upper respiratory tract infection |
VO2 | = | Volume of oxygen utilization |
WGO | = | World Gastroenterology Organization |
WHO | = | World Health Organization |
Acknowledgments
The authors would like to thank the participants and researchers who contributed works cited in this paper.
Funding
This position stand was commissioned by the Editors of the Journal of the International Society of Sports Nutrition. The authors received no remuneration for writing and/or reviewing this position stand.
Availability of data and materials
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- HillCGuarnerFReidGGibsonGRMerensteinDJPotBMorelliLCananiRBFlintHJSalminenS et al Expert consensus document. The international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probioticNat Rev Gastroenterol Hepatol201411 506 514 https://doi.org/10.1038/nrgastro.2014.66 24912386 24912386
- GibsonGRHutkinsRSandersMEPrescottSLReimerRASalminenSJScottKStantonCSwansonKSCaniPD et al Expert consensus document: the international scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebioticsNat Rev Gastroenterol Hepatol201714 491 502 https://doi.org/10.1038/nrgastro.2017.75 28611480 28611480
- de VreseMichaelSchrezenmeirJ.Probiotics, Prebiotics, and SynbioticsFood Biotechnology2008 Berlin, Heidelberg Springer Berlin Heidelberg 1 66
- Aguilar-toalaJGarcia-PerezRGarciaHMata-HaroVGonzalez-CordovaAVallego-CordobaBHernandez-MendozaAPostbiotics: An evolving term within the functional foods fieldTrends Food Sci Technol201875 105 114 https://doi.org/10.1016/j.tifs.2018.03.009 1:CAS:528:DC%2BC1cXltVyjsbs%3D
- MaughanRJBurkeLMDvorakJLarson-MeyerDEPeelingPPhillipsSMRawsonESWalshNPGartheIGeyerH et al IOC consensus statement: dietary supplements and the high-performance athleteBr J Sports Med201852 439 455 https://doi.org/10.1136/bjsports-2018-099027 29540367 5867441
- RowlandICapursoLCollinsKCummingsJDelzenneNGouletOGuarnerFMarteauPMeierRCurrent level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009Gut Microbes20101 436 439 https://doi.org/10.4161/gmic.1.6.13610 21637035 3056112
- MetchnikoffE The prolongated of life; optimistic studies1908 New York G.P. Putnam’s Son
- DurantiSFerrarioCvan SinderenDVenturaMTurroniFObesity and microbiota: an example of an intricate relationshipGenes Nutr201712 18 https://doi.org/10.1186/s12263-017-0566-2 28638490 5473000
- StaleyJTBiodiversity: are microbial species threatened?Curr Opin Biotechnol19978 340 345 9206017 https://doi.org/10.1016/S0958-1669(97)80014-6 1:CAS:528:DyaK2sXjvFWjtr4%3D 9206017
- PyneDBWestNPCoxAJCrippsAWProbiotics supplementation for athletes - clinical and physiological effectsEur J Sport Sci201515 63 72 https://doi.org/10.1080/17461391.2014.971879 25339255 25339255
- CostelloEKLauberCLHamadyMFiererNGordonJIKnightRBacterial community variation in human body habitats across space and timeScience16942009 326 https://doi.org/10.1126/science.1177486 1:CAS:528:DC%2BD1MXhsFGmsL7K 1697
- DuffyLCRaitenDJHubbardVSStarke-ReedPProgress and challenges in developing metabolic footprints from diet in human gut microbial cometabolismJ Nutr2015145 1123S 1130S https://doi.org/10.3945/jn.114.194936 25833886 4410496 1:CAS:528:DC%2BC2MXptlGns70%3D
- YatsunenkoTReyFEManaryMJTrehanIDominguez-BelloMGContrerasMMagrisMHidalgoGBaldassanoRNAnokhinAP et al Human gut microbiome viewed across age and geographyNature2012486 222 227 https://doi.org/10.1038/nature11053 22699611 3376388 1:CAS:528:DC%2BC38Xos1emtLc%3D
- ZhouYMihindukulasuriyaKAGaoHLa RosaPSWylieKMMartinJCKotaKShannonWDMitrevaMSodergrenE et al Exploration of bacterial community classes in major human habitatsGenome Biol201415 R66 https://doi.org/10.1186/gb-2014-15-5-r66 24887286 4073010
- BressaCBailen-AndrinoMPerez-SantiagoJGonzalez-SolteroRPerezMMontalvo-LomincharMGMate-MunozJLDominguezRMorenoDLarrosaMDifferences in gut microbiota profile between women with active lifestyle and sedentary womenPLoS One201712 e0171352 https://doi.org/10.1371/journal.pone.0171352 28187199 5302835 1:CAS:528:DC%2BC2sXhvF2rs7bP
- ClarkeSFMurphyEFO'SullivanOLuceyAJHumphreysMHoganAHayesPO'ReillyMJefferyIBWood-MartinR et al Exercise and associated dietary extremes impact on gut microbial diversityGut19132014 63 https://doi.org/10.1136/gutjnl-2013-306541 1:CAS:528:DC%2BC2MXhs1ejsA%3D%3D 1920
- PetersenLMBautistaEJNguyenHHansonBMChenLLekSHSodergrenEWeinstockGMCommunity characteristics of the gut microbiomes of competitive cyclistsMicrobiome20175 98 https://doi.org/10.1186/s40168-017-0320-4 28797298 5553673
- MorklSLacknerSMullerWGorkiewiczGKashoferKOberascherAPainoldAHollAHolzerPMeinitzerA et al Gut microbiota and body composition in anorexia nervosa inpatients in comparison to athletes, overweight, obese, and normal weight controlsInt J Eat Disord201750 1421 1431 https://doi.org/10.1002/eat.22801 29131365 29131365
- BartonWPenneyNCCroninOGarcia-PerezIMolloyMGHolmesEShanahanFCotterPDO'SullivanOThe microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic levelGut201867 625 633 https://doi.org/10.1136/gutjnl-2016-313627 28360096 1:CAS:528:DC%2BC1cXit1Wgur7O 28360096
- EstakiMPitherJBaumeisterPLittleJPGillSKGhoshSAhmadi-VandZMarsdenKRGibsonDLCardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functionsMicrobiome20164 42 https://doi.org/10.1186/s40168-016-0189-7 27502158 4976518
- CerdaBPerezMPerez-SantiagoJDTornero-AguileraJFGonzalez-SolteroRLarrosaMGut microbiota modification: another piece in the puzzle of the benefits of physical exercise in health?Front Physiol20167 51 https://doi.org/10.3389/fphys.2016.00051 26924990 4757670
- ChoiJJEumSYRampersaudEDaunertSAbreuMTToborekMExercise attenuates PCB-induced changes in the mouse gut microbiomeEnviron Health Perspect2013121 725 730 https://doi.org/10.1289/ehp.1306534 23632211 3672930
- EvansCCLePardKJKwakJWStancukasMCLaskowskiSDoughertyJMoultonLGlaweAWangYLeoneV et al Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesityPLoS One20149 e92193 https://doi.org/10.1371/journal.pone.0092193 24670791 3966766 1:CAS:528:DC%2BC2cXhsVKitrzM
- PetrizBACastroAPAlmeidaJAGomesCPFernandesGRKrugerRHPereiraRWFrancoOLExercise induction of gut microbiota modifications in obese, non-obese and hypertensive ratsBMC Genomics201415 511 https://doi.org/10.1186/1471-2164-15-511 24952588 4082611
- Queipo-OrtunoMISeoaneLMMurriMPardoMGomez-ZumaqueroJMCardonaFCasanuevaFTinahonesFJGut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levelsPLoS One20138 e65465 https://doi.org/10.1371/journal.pone.0065465 23724144 3665787 1:CAS:528:DC%2BC3sXptlyhtbc%3D
- CampbellSCWisniewskiPJNojiMMcGuinnessLRHaggblomMMLightfootSAJosephLBKerkhofLJThe effect of diet and exercise on intestinal integrity and microbial diversity in micePLoS One201611 e0150502 https://doi.org/10.1371/journal.pone.0150502 26954359 4783017 1:CAS:528:DC%2BC28XhsFGjtL%2FE
- CookMDMartinSAWilliamsCWhitlockKWalligMAPenceBDWoodsJAForced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitisBrain Behav Immun201333 46 56 https://doi.org/10.1016/j.bbi.2013.05.005 23707215 3775960
- AllenJMMailingLJNiemiroGMMooreRCookMDWhiteBAHolscherHDWoodsJAExercise alters gut microbiota composition and function in lean and obese humansMed Sci Sports Exerc201850 747 757 https://doi.org/10.1249/MSS.0000000000001495 29166320 29166320
- MatsumotoMInoueRTsukaharaTUshidaKChijiHMatsubaraNHaraHVoluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecumBiosci Biotechnol Biochem200872 572 576 https://doi.org/10.1271/bbb.70474 18256465 1:CAS:528:DC%2BD1cXjsVWrs7w%3D 18256465
- ScheimanJLuberJMChavkinTAMacDonaldTTungAPhamLDWibowoMCWurthRCPunthambakerSTierneyBT et al Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolismNat Med201925 1104 1109 https://doi.org/10.1038/s41591-019-0485-4 31235964 1:CAS:528:DC%2BC1MXht1eku7jM 31235964
- CroninOO'SullivanOBartonWCotterPDMolloyMGShanahanFGut microbiota: implications for sports and exercise medicineBr J Sports Med201751 700 701 https://doi.org/10.1136/bjsports-2016-097225 28077354 28077354
- DavidLAMauriceCFCarmodyRNGootenbergDBButtonJEWolfeBELingAVDevlinASVarmaYFischbachMA et al Diet rapidly and reproducibly alters the human gut microbiomeNature2014505 559 563 https://doi.org/10.1038/nature12820 24336217 1:CAS:528:DC%2BC2cXhtFOls78%3D 24336217
- WuGDChenJHoffmannCBittingerKChenYYKeilbaughSABewtraMKnightsDWaltersWAKnightR et al Linking long-term dietary patterns with gut microbial enterotypesScience2011334 105 108 https://doi.org/10.1126/science.1208344 21885731 3368382 1:CAS:528:DC%2BC3MXht1Gms77K
- SheflinAMMelbyCLCarboneroFWeirTLLinking dietary patterns with gut microbial composition and functionGut Microbes20178 113 129 https://doi.org/10.1080/19490976.2016.1270809 27960648 1:CAS:528:DC%2BC2sXlsFSitQ%3D%3D 27960648
- Moreno-PérezDiegoBressaCarloBailénMaríaHamed-BousdarSafaNaclerioFernandoCarmonaManuelPérezMargaritaGonzález-SolteroRocíoMontalvo-LomincharMariaCarabañaClaudiaLarrosaMarEffect of a Protein Supplement on the Gut Microbiota of Endurance Athletes: A Randomized, Controlled, Double-Blind Pilot StudyNutrients201810 3 337 5872755 https://doi.org/10.3390/nu10030337 1:CAS:528:DC%2BC1cXitlOjt77I
- GleesonMImmune function in sport and exerciseJ App Physiol (1985)2007103 693 699 https://doi.org/10.1152/japplphysiol.00008.2007 1:CAS:528:DC%2BD2sXhtVShs7%2FL
- TapJFuretJPBensaadaMPhilippeCRothHRabotSLakhdariOLombardVHenrissatBCorthierG et al Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adultsEnviron Microbiol201517 4954 4964 https://doi.org/10.1111/1462-2920.13006 26235304 1:CAS:528:DC%2BC28XjtVOntA%3D%3D 26235304
- CrampTBroadEMartinDMeyerBJEffects of preexercise carbohydrate ingestion on mountain bike performanceMed Sci Sports Exerc16022004 36 1609
- CaesarRTremaroliVKovatcheva-DatcharyPCaniPDBackhedFCrosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signalingCell Metab201522 658 668 https://doi.org/10.1016/j.cmet.2015.07.026 26321659 4598654 1:CAS:528:DC%2BC2MXhsVajs73I
- RawsonESMilesMPLarson-MeyerDEDietary supplements for health, adaptation, and recovery in athletesInt J Sport Nutr Exerc Metab201828 188 199 https://doi.org/10.1123/ijsnem.2017-0340 29345167 1:CAS:528:DC%2BC1MXht1yhtb7E 29345167
- de OliveiraEPBuriniRCJeukendrupAGastrointestinal complaints during exercise: prevalence, etiology, and nutritional recommendationsSports Med201444 Suppl 1 S79 S85 https://doi.org/10.1007/s40279-014-0153-2 24791919 24791919
- JägerRalfPurpuraMartinStoneJasonTurnerStephanieAnzaloneAnthonyEimerbrinkMicahPaneMarcoAmorusoAngelaRowlandsDavidOliverJonathanProbiotic Streptococcus thermophilus FP4 and Bifidobacterium breve BR03 Supplementation Attenuates Performance and Range-of-Motion Decrements Following Muscle Damaging ExerciseNutrients20168 10 642 5084029 https://doi.org/10.3390/nu8100642 1:CAS:528:DC%2BC1cXhsFShurk%3D
- JägerRalfShieldsKevin A.LoweryRyan P.De SouzaEduardo O.PartlJeremy M.HollmerChasePurpuraMartinWilsonJacob M.ProbioticBacillus coagulansGBI-30, 6086 reduces exercise-induced muscle damage and increases recoveryPeerJ20164 e2276 27547577 4963221 https://doi.org/10.7717/peerj.2276 1:CAS:528:DC%2BC1cXotl2gtbw%3D
- SalarkiaNGhadamliLZaeriFSabaghian RadLEffects of probiotic yogurt on performance, respiratory and digestive systems of young adult female endurance swimmers: a randomized controlled trialMed J Islam Repub Iran201327 141 146 24791124 3917487
- SalehzadehKThe effects of probiotic yogurt drink on lipid profile, CRP, and record changes in aerobic athletesLife Sci20159 32 37
- ShingCMPeakeJMLimCLBriskeyDWalshNPFortesMBAhujaKDVitettaLEffects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heatEur J Appl Physiol2014114 93 103 https://doi.org/10.1007/s00421-013-2748-y 24150782 24150782
- KlaenhammerTRKleerebezemMKoppMVRescignoMThe impact of probiotics and prebiotics on the immune systemNat Rev Immunol201212 728 734 https://doi.org/10.1038/nri3312 23007572 1:CAS:528:DC%2BC38XhsVSltLrL 23007572
- SangLXChangBZhangWLWuXMLiXHJiangMRemission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysisWorld J Gastroenterol19082010 16 1915
- NgSCHartALKammMAStaggAJKnightSCMechanisms of action of probiotics: recent advancesInflamm Bowel Dis200915 300 310 https://doi.org/10.1002/ibd.20602 18626975 1:STN:280:DC%2BD1M%2FmslCjsw%3D%3D 18626975
- Plaza-DiazJGomez-LlorenteCFontanaLGilAModulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probioticsWorld J Gastroenterol201420 15632 15649 https://doi.org/10.3748/wjg.v20.i42.15632 25400447 4229528 1:CAS:528:DC%2BC2cXitVSjsr%2FN
- MiettinenMVuopio-VarkilaJVarkilaKProduction of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteriaInfect Immun199664 5403 5405 8945595 174537 1:CAS:528:DyaK28XntF2jtLY%3D
- NazemianVShadnoushMManahejiHZaringhalamJProbiotics and inflammatory pain: a literature review studyMiddle East J Rehab Health20163 e36087
- ClancyRLGleesonMCoxACallisterRDorringtonMD'EsteCPangGPyneDFrickerPHenrikssonAReversal in fatigued athletes of a defect in interferon gamma secretion after administration of Lactobacillus acidophilusBr J Sports Med200640 351 354 https://doi.org/10.1136/bjsm.2005.024364 16556792 2577537 1:STN:280:DC%2BD287mslajuw%3D%3D
- MoreiraAKekkonenRKorpelaRDelgadoLHaahtelaTAllergy in marathon runners and effect of Lactobacillus GG supplementation on allergic inflammatory markersRespir Med2007101 1123 1131 https://doi.org/10.1016/j.rmed.2006.11.015 17196811 17196811
- KekkonenRAVasankariTJVuorimaaTHaahtelaTJulkunenIKorpelaRThe effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runnersInt J Sport Nutr Exerc Metab200717 352 363 17962710 https://doi.org/10.1123/ijsnem.17.4.352 17962710
- TiollierEChennaouiMGomez-MerinoDDrogouCFilaireEGuezennecCYEffect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military trainingMil Med2007172 1006 1011 https://doi.org/10.7205/milmed.172.9.1006 17937368 17937368
- CoxAJPyneDBSaundersPUFrickerPAOral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletesBr J Sports Med201044 222 226 https://doi.org/10.1136/bjsm.2007.044628 18272539 1:STN:280:DC%2BC3c3gslyrsQ%3D%3D 18272539
- MartarelliDVerdenelliMCScuriSCocchioniMSilviSCecchiniCPompeiPEffect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise trainingCurr Microbiol16892011 62 https://doi.org/10.1007/s00284-011-9915-3 1:CAS:528:DC%2BC3MXlsVGgsbs%3D 1696
- GleesonMBishopNCStenselDJLindleyMRMastanaSSNimmoMAThe anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of diseaseNat Rev Immunol201111 607 615 https://doi.org/10.1038/nri3041 21818123 1:CAS:528:DC%2BC3MXpvVOktbo%3D 21818123
- GleesonMBishopNCOliveiraMTaulerPDaily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletesInt J Sport Nutr Exerc Metab201121 55 64 21411836 https://doi.org/10.1123/ijsnem.21.1.55 21411836
- WestNPPyneDBCrippsAWHopkinsWGEskesenDCJairathAChristophersenCTConlonMAFrickerPALactobacillus fermentum (PCC(R)) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletesNutr J201110 30 https://doi.org/10.1186/1475-2891-10-30 21477383 3083335
- VälimäkiI.VuorimaaT.AhotupaM.KekkonenR.KorpelaR.VasankariT.Decreased Training Volume and Increased Carbohydrate Intake Increases Oxidized LDL LevelsInternational Journal of Sports Medicine201233 04 291 296 22377944 https://doi.org/10.1055/s-0031-1291223 1:CAS:528:DC%2BC38XpsFKrs7w%3D 22377944
- LamprechtMBognerSSchippingerGSteinbauerKFankhauserFHallstroemSSchuetzBGreilbergerJFProbiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trialJ Int Soc Sports Nutr20129 45 https://doi.org/10.1186/1550-2783-9-45 22992437 3465223 1:CAS:528:DC%2BC38XhvVSiur%2FK
- GleesonMBishopNOliveiraMMcCauleyTTaulerPMuhamadASRespiratory infection risk in athletes: association with antigen-stimulated IL-10 production and salivary IgA secretionScand J Med Sci Sports201222 410 417 https://doi.org/10.1111/j.1600-0838.2010.01272.x 21385218 1:STN:280:DC%2BC38zjvVSgug%3D%3D 21385218
- Grobbelaar et al. The influence of probiotic supplementation on selected athletic performance-related blood markers in men. African Journal for Physical, Health Education, Recreation and Dance. 2012;18(1):1–11.
- WestNPPyneDBCrippsAWChristophersenCTConlonMAFrickerPAGut balance, a synbiotic supplement, increases fecal Lactobacillus paracasei but has little effect on immunity in healthy physically active individualsGut Microbes20123 221 227 https://doi.org/10.4161/gmic.19579 22572834 3427214
- SashiharaTNagataMMoriTIkegamiSGotohMOkuboKUchidaMItohHEffects of Lactobacillus gasseri OLL2809 and alpha-lactalbumin on university-student athletes: a randomized, double-blind, placebo-controlled clinical trialAppl Physiol Nutr Metab201338 1228 1235 https://doi.org/10.1139/apnm-2012-0490 24195623 1:CAS:528:DC%2BC3sXhsFOiurzE 24195623
- WestNPHornPLPyneDBGebskiVJLahtinenSJFrickerPACrippsAWProbiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individualsClin Nutr201433 581 587 https://doi.org/10.1016/j.clnu.2013.10.002 24268677 1:CAS:528:DC%2BC3sXhvVahurjP 24268677
- HaywoodBABlackKEBakerDMcGarveyJHealeyPBrownRCProbiotic supplementation reduces the duration and incidence of infections but not severity in elite rugby union playersJ Sci Med Sport201417 356 360 https://doi.org/10.1016/j.jsams.2013.08.004 24045086 24045086
- AghaeeMKhosraviNHanachiPKordiMRAghaeeREffect of probiotic supplement on immune response in male athletesQom Univ Med Sci20147 27 33
- GeorgesJLoweryRYamanGKerioCOrmesJMcClearySSharpMShieldsKRauchJSilvaJ et al The effects of probiotic supplementation on lean body mass, strength, power, and health indicators in resistance trained males: a pilot studyJ Int Soc Sports Nutr201411 P38 4271634 https://doi.org/10.1186/1550-2783-11-S1-P38
- Narimani-Rad et al. Indian Journal of Fundamental and Applied Life Sciences (Online) An Open Access, Online International Journal Available at www.cibtech.org/sp.ed/jls/2014/03/jls.htm. 2014;4(S3):231–5. ISSN: 2231–6345.
- MuhamadAGleesonMEffects of a 14-strain probiotics supplement on salivary antimicrobial proteins at rest and in reponse to an acute bout of prolonged exerciseInt J Sports Sci20144 60 66
- O’BrienKVStewartLKForneyLAAryanaKJPrinyawiwatkulWBoenekeCAThe effects of postexercise consumption of a kefir beverage on performance and recovery during intensive endurance trainingJ Dairy Sci201598 7446 7449 https://doi.org/10.3168/jds.2015-9392 26298752 1:CAS:528:DC%2BC2MXhtlKkur%2FM 26298752
- GillSKTeixeiraAMRosadoFCoxMCostaRJHigh-dose probiotic supplementation containing Lactobacillus casei for 7 days does not enhance salivary antimicrobial protein responses to exertional heat stress compared with placeboInt J Sport Nutr Exerc Metab201626 150 160 https://doi.org/10.1123/ijsnem.2015-0171 26479711 1:CAS:528:DC%2BC1cXmsFCqtL4%3D 26479711
- GillSKAllertonDMAnsley-RobsonPHemmingsKCoxMCostaRJDoes short-term high dose probiotic supplementation containing Lactobacillus casei attenuate exertional-heat stress induced Endotoxaemia and Cytokinaemia?Int J Sport Nutr Exerc Metab201626 268 275 https://doi.org/10.1123/ijsnem.2015-0186 26568577 1:CAS:528:DC%2BC1cXnt1Kkt7g%3D 26568577
- RobertsJustinSucklingCraigPeedleGeorgiaMurphyJosephDawkinsTonyRobertsMichaelAn Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant InterventionNutrients20168 11 733 5133117 https://doi.org/10.3390/nu8110733
- StrasserBarbaraGeigerDanielaSchauerMarkusGostnerJohannaGattererHannesBurtscherMartinFuchsDietmarProbiotic Supplements Beneficially Affect Tryptophan–Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled TrialNutrients20168 11 752 5133134 https://doi.org/10.3390/nu8110752
- MichalickovaDMinicRDikicNAndjelkovicMKostic-VucicevicMStojmenovicTNikolicIDjordjevicBLactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trialAppl Physiol Nutr Metab201641 782 789 https://doi.org/10.1139/apnm-2015-0541 27363733 1:CAS:528:DC%2BC28XhtFSit7bM 27363733
- GleesonMBishopNCStruszczakLEffects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trialEur J Appl Physiol2016116 1555 1563 https://doi.org/10.1007/s00421-016-3415-x 27294502 4943997 1:CAS:528:DC%2BC28Xpslahsb0%3D
- MarshallHChrismasBCRSucklingCARobertsJDFosterJTaylorLChronic probiotic supplementation with or without glutamine does not influence the eHsp72 response to a multi-day ultra-endurance exercise eventAppl Physiol Nutr Metab201742 876 883 https://doi.org/10.1139/apnm-2017-0131 28460195 1:CAS:528:DC%2BC2sXhtVarsrzJ 28460195
- BrennanConnery J.AxelrodChristopher L.PaulDeborahHullMichaelaKirwanJohn P.Effects Of A Novel Probiotic On Exercise-Induced Gut Permeability and Microbiota in Endurance AthletesMedicine & Science in Sports & Exercise201850 840 https://doi.org/10.1249/01.mss.0000538764.55259.9c
- TownsendJeremyBenderDavidVantreaseWilliamSappPhilipToyAnnWoodsClintJohnsonKentEffects of Probiotic (Bacillus subtilis DE111) Supplementation on Immune Function, Hormonal Status, and Physical Performance in Division I Baseball PlayersSports20186 3 70 6162611 https://doi.org/10.3390/sports6030070
- Antonio J, Leaf A, Carson C, Ellerbroek A, Axelrod C, Silver T, Burgess V, Peacock C. The effects of probiotic supplementation in active men and women. J Exerc Nutr. 2018;1.
- HuangWCHsuYJLiHKanNWChenYMLinJSHsuTKTsaiTYChiuYSHuangCCEffect of Lactobacillus Plantarum TWK10 on improving endurance performance in humansChin J Phys201861 163 170 https://doi.org/10.4077/CJP.2018.BAH587 1:CAS:528:DC%2BC1MXhs1anu7%2FK
- CarbuhnAaronReynoldsShelbyCampbellClarkBradfordLukeDeckertJakeKreutzerAndreasFryAndrewEffects of Probiotic (Bifidobacterium longum 35624) Supplementation on Exercise Performance, Immune Modulation, and Cognitive Outlook in Division I Female SwimmersSports20186 4 116 6315752 https://doi.org/10.3390/sports6040116
- HuangWen-ChingWeiChen-ChanHuangChi-ChangChenWen-LinHuangHui-YuThe Beneficial Effects of Lactobacillus plantarum PS128 on High-Intensity, Exercise-Induced Oxidative Stress, Inflammation, and Performance in TriathletesNutrients201911 2 353 6412901 https://doi.org/10.3390/nu11020353 1:CAS:528:DC%2BC1MXhtlOrsbnK
- PughJamie N.SparksAndy S.DoranDominic A.FlemingSimon C.Langan-EvansCarlKirkBenFearnRobertMortonJames P.CloseGraeme L.Four weeks of probiotic supplementation reduces GI symptoms during a marathon raceEuropean Journal of Applied Physiology2019119 7 1491 1501 30982100 6570661 https://doi.org/10.1007/s00421-019-04136-3
- PumpaKate L.McKuneAndrew J.HarnettJoannaA novel role of probiotics in improving host defence of elite rugby union athlete: A double blind randomised controlled trialJournal of Science and Medicine in Sport201922 8 876 881 31006545 https://doi.org/10.1016/j.jsams.2019.03.013 31006545
- VaisbergMauroPaixãoVitoriaAlmeidaEwinSantosJulianaFosterRobertaRossiMarceloPithon-CuriTaniaGorjãoRenataMomessoCesarAndradeMaríliaAraujoJoséGarciaMaurícioCohenMoisesPerezElizabethSantos-DiasAlanaVieiraRodolfoBachiAndréDaily Intake of Fermented Milk Containing Lactobacillus casei Shirota (Lcs) Modulates Systemic and Upper Airways Immune/Inflammatory Responses in Marathon RunnersNutrients201911 7 1678 6682935 https://doi.org/10.3390/nu11071678
- MeeusenRExercise, nutrition and the brainSports Med201444 Suppl 1 S47 S56 https://doi.org/10.1007/s40279-014-0150-5 24791916 24791916
- ChenYMWeiLChiuYSHsuYJTsaiTYWangMFHuangCCLactobacillus plantarum TWK10 supplementation improves exercise performance and increases muscle mass in miceNutrients20168 205 https://doi.org/10.3390/nu8040205 27070637 4848674 1:CAS:528:DC%2BC2sXmvVajtLs%3D
- WangXShaoCLiuLGuoXXuYLuXOptimization, partial characterization and antioxidant activity of an exopolysaccharide from Lactobacillus plantarum KX041Int J Biol Macromol2017103 1173 1184 https://doi.org/10.1016/j.ijbiomac.2017.05.118 28551435 1:CAS:528:DC%2BC2sXhtVyhtrbE 28551435
- StorelliGDefayeAErkosarBHolsPRoyetJLeulierFLactobacillus plantarum promotes Drosophila systemic growth by modulating hormonal signals through TOR-dependent nutrient sensingCell Metab201114 403 414 https://doi.org/10.1016/j.cmet.2011.07.012 21907145 1:CAS:528:DC%2BC3MXhtFGltbbP 21907145
- SchwarzerMMakkiKStorelliGMachuca-GayetISrutkovaDHermanovaPMartinoMEBalmandSHudcovicTHeddiA et al Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutritionScience2016351 854 857 https://doi.org/10.1126/science.aad8588 26912894 1:CAS:528:DC%2BC28XisFOjsLo%3D 26912894
- MinevichJOlsonMMannionJBoublikJMcPersonJLoweryRShieldsKSharpMDe SouzaEWilsonJ et al Digestive enzymes reduce quality difference between plant and animal proteins: a double-blind crossover study (abstract)J Int Soc Sports Nutr201512 P26 4595032 https://doi.org/10.1186/1550-2783-12-S1-P26
- WangYGuQEffect of probiotic on growth performance and digestive enzyme activity of arbor acres broilersRes Vet Sci201089 163 167 https://doi.org/10.1016/j.rvsc.2010.03.009 20350733 1:CAS:528:DC%2BC3cXhtVGmtrnN 20350733
- KimmelMKellerDFarmerSWarrinoDEA controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markersMethods Find Exp Clin Pharmacol201032 129 132 https://doi.org/10.1358/mf.2010.32.2.1423881 20401350 1:CAS:528:DC%2BC3cXnsl2ls7g%3D 20401350
- MaathuisAJKellerDFarmerSSurvival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestineBenefic Microbes20101 31 36 https://doi.org/10.3920/BM2009.0009 1:CAS:528:DC%2BC3MXhsFGru7rP
- KlemenakMDolinsekJLangerholcTDi GioiaDMicetic-TurkDAdministration of Bifidobacterium breve decreases the production of TNF-alpha in children with celiac diseaseDig Dis Sci201560 3386 3392 https://doi.org/10.1007/s10620-015-3769-7 26134988 1:CAS:528:DC%2BC2MXhtFGlur3L 26134988
- NicolaSMognaLAllesinaSBarbaMDeiddaFLorenziniPRaiteriEStrozziGMognaGInteraction between probiotics and human immune cells. The prospective anti-inflammatory activity of Bifidobacterium breve BRO3Agro Food Ind Hi-Tech201021 9 13
- SaggioroAProbiotics in the treatment of irritable bowel syndromeJ Clin Gastroenterol200438 S104 S106 15220671 https://doi.org/10.1097/01.mcg.0000129271.98814.e2 15220671
- Toohey JC, Townsend JR, Johnson SB, Toy AM, Vantrease WC, Bender D, Crimi CC, Stowers KL, Ruiz MD, VanDusseldorp TA, et al. Effects of probiotic (Bacillus subtilis) supplementation during offseason resistance training in female division I athletes. J Strength Cond Res. 2018. https://doi.org/https://doi.org/10.1519/JSC.0000000000002675.
- MekkesMCWeenenTCBrummerRJClaassenEThe development of probiotic treatment in obesity: a reviewBenefic Microbes20145 19 28 https://doi.org/10.3920/BM2012.0069 1:STN:280:DC%2BC3sfktFajuw%3D%3D
- MinamiJKondoSYanagisawaNOdamakiTXiaoJZAbeFNakajimaSHamamotoYSaitohSShimodaTOral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trialJ Nutr Sci20154 e17 https://doi.org/10.1017/jns.2015.5 26090097 4463018 1:CAS:528:DC%2BC2MXhtVGhu7bM
- KondoSXiaoJZSatohTOdamakiTTakahashiSSugaharaHYaeshimaTIwatsukiKKameiAAbeKAntiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesityBiosci Biotechnol Biochem16562010 74 https://doi.org/10.1271/bbb.100267 1:CAS:528:DC%2BC3cXhtlCktL%2FN 1661
- HardinBJCampbellKSSmithJDArbogastSSmithJMoylanJSReidMBTNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscleJ App Physiol (1985)2008104 694 699 https://doi.org/10.1152/japplphysiol.00898.2007 1:CAS:528:DC%2BD1cXkt1Oht7Y%3D
- LangCHFrostRANairnACMacLeanDAVaryTCTNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiationAm J Physiol Endocrinol Metab2002282 E336 E347 https://doi.org/10.1152/ajpendo.00366.2001 11788365 1:CAS:528:DC%2BD38XhtFGit7Y%3D 11788365
- MainLCDawsonBHeelKGroveJRLandersGJGoodmanCRelationship between inflammatory cytokines and self-report measures of training overloadRes Sports Med (Print)201018 127 139 https://doi.org/10.1080/15438621003627133
- KristensenNBBryrupTAllinKHNielsenTHansenTHPedersenOAlterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trialsGenome Med20168 52 https://doi.org/10.1186/s13073-016-0300-5 27159972 4862129 1:CAS:528:DC%2BC2sXjtFOgsrs%3D
- McFarlandLVUse of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic reviewBMJ Open20144 e005047 https://doi.org/10.1136/bmjopen-2014-005047 25157183 4156804
- TurnbaughPJHamadyMYatsunenkoTCantarelBLDuncanALeyRESoginMLJonesWJRoeBAAffourtitJP et al A core gut microbiome in obese and lean twinsNature2009457 480 484 https://doi.org/10.1038/nature07540 19043404 1:CAS:528:DC%2BD1MXotlOlsw%3D%3D 19043404
- DonmezNKisadereIBalabanCKadiralievaNEffects of traditional homemade koumiss on some hematological and biochemical characteristics in sedentary men exposed to exerciseBiotech Histochem201489 558 563 https://doi.org/10.3109/10520295.2014.915428 24893332 1:CAS:528:DC%2BC2cXhvVelu7vL 24893332
- LolloPCCruzAGMoratoPNMouraCSCarvalho-SilvaLBOliveiraCAFariaJAAmaya-FarfanJProbiotic cheese attenuates exercise-induced immune suppression in Wistar ratsJ Dairy Sci201295 3549 3558 https://doi.org/10.3168/jds.2011-5124 22720913 1:CAS:528:DC%2BC38XoslGlsLk%3D 22720913
- WellsJMRossiOMeijerinkMvan BaarlenPEpithelial crosstalk at the microbiota-mucosal interfaceProc Natl Acad Sci U S A2011108 Suppl 1 4607 4614 https://doi.org/10.1073/pnas.1000092107 20826446 20826446
- SchwellnusMSoligardTAlonsoJMBahrRClarsenBDijkstraHPGabbettTJGleesonMHagglundMHutchinsonMR et al How much is too much? (part 2) International Olympic Committee consensus statement on load in sport and risk of illnessBr J Sports Med201650 1043 1052 https://doi.org/10.1136/bjsports-2016-096572 27535991 5013087
- GeukingMBMcCoyKDMacphersonAJMetabolites from intestinal microbes shape TregCell Res201323 1339 1340 https://doi.org/10.1038/cr.2013.125 24018374 3847568 1:CAS:528:DC%2BC3sXhsVWru7bL
- HiramatsuYHosonoAKonnoTNakanishiYMutoMSuyamaAHachimuraSSatoRTakahashiKKaminogawaSOrally administered Bifidobacterium triggers immune responses following capture by CD11c(+) cells in Peyer's patches and cecal patchesCytotechnology201163 307 317 https://doi.org/10.1007/s10616-011-9349-6 21461945 3081045
- ShephardRJSpecial feature for the Olympics: effects of exercise on the immune system: overview of the epidemiology of exercise immunologyImmunol Cell Biol200078 485 495 https://doi.org/10.1111/j.1440-1711.2000.t01-1-.x 11050531 1:STN:280:DC%2BD3crgt1CqsQ%3D%3D 11050531
- ChakravartiAThe CD4/CD8 ratio: message in a bottle?Nat Med19951 1240 1241 https://doi.org/10.1038/nm1295-1240 7489396 1:CAS:528:DyaK2MXpslGhtL0%3D 7489396
- SandersMMerensteinDMerrifieldCHutkinsRProbiotics for Human UseNutr Bull201943 212 225 https://doi.org/10.1111/nbu.12334
- AzadMAKSarkerMWanDImmunomodulatory effects of probiotics on cytokine profilesBiomed Res Int20182018 8063647 https://doi.org/10.1155/2018/8063647 30426014 6218795 1:CAS:528:DC%2BC1MXnsl2ktbk%3D
- ŠuškovićJKosBNovakJPavuncAHabjaničKMatoćSAntimicrobial activity - the most important property of probiotic and starter lactic acid bacteriaFood Technol Biotechnol201048 296 307
- DobsonACotterPDRossRPHillCBacteriocin production: a probiotic trait?Appl Environ Microbiol201278 1 6 https://doi.org/10.1128/AEM.05576-11 22038602 3255625 1:CAS:528:DC%2BC38XjsVKktb0%3D
- CotterPDHillCRossRPBacteriocins: developing innate immunity for foodNat Rev Microbiol20053 777 788 https://doi.org/10.1038/nrmicro1273 16205711 1:CAS:528:DC%2BD2MXhtVGrurbF 16205711
- WosinskaLauraCotterPaul D.O’SullivanOrlaGuinaneCaitrionaThe Potential Impact of Probiotics on the Gut Microbiome of AthletesNutrients201911 10 2270 6835687 https://doi.org/10.3390/nu11102270
- RehrerNJvan KemenadeMMeesterWBrounsFSarisWHGastrointestinal complaints in relation to dietary intake in triathletesInt J Sport Nutr19922 48 59 1338583 https://doi.org/10.1123/ijsn.2.1.48 1:STN:280:DyaK3s3jtVaksQ%3D%3D 1338583
- van WijckKLenaertsKGrootjansJWijnandsKAPoezeMvan LoonLJDejongCHBuurmanWAPhysiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: strategies for evaluation and preventionAm J Physiol Gastrointest Liver Physiol2012303 G155 G168 https://doi.org/10.1152/ajpgi.00066.2012 22517770 1:CAS:528:DC%2BC38Xht1Oksr%2FK 22517770
- van WijckKLenaertsKvan LoonLJPetersWHBuurmanWADejongCHExercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy menPLoS One20116 e22366 https://doi.org/10.1371/journal.pone.0022366 21811592 3141050 1:CAS:528:DC%2BC3MXhtVGhtL7I
- JeukendrupAEJentjensRLMoseleyLNutritional considerations in triathlonSports Med200535 163 181 15707379 https://doi.org/10.2165/00007256-200535020-00005 15707379 doi:3525 [pii]
- JeukendrupAETraining the gut for athletesSports Med201747 101 110 https://doi.org/10.1007/s40279-017-0690-6 28332114 5371619
- Brennan, C.J.; Axelrod, C.; Paul, D.; Hull, M.; Kirwan, J.P. Effects of a novel probiotic on exercise-induced gut permeability and microbiota in endurance athletes (abstract). In proceedings of American College of Sports Medicine, Minneapolis, MN.
- FasanoAZonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancerPhysiol Rev201191 151 175 https://doi.org/10.1152/physrev.00003.2008 21248165 1:CAS:528:DC%2BC3MXisVCht78%3D 21248165
- de OliveiraEPBuriniRCFood-dependent, exercise-induced gastrointestinal distressJ Int Soc Sports Nutr20118 12 https://doi.org/10.1186/1550-2783-8-12 21955383 3190328 1:CAS:528:DC%2BC3MXhs1Oqur7N
- GroschwitzKRHoganSPIntestinal barrier function: molecular regulation and disease pathogenesisJ Allergy Clin Immunol2009124 3 20 https://doi.org/10.1016/j.jaci.2009.05.038 19560575 4266989 1:CAS:528:DC%2BD1MXnsl2gu7k%3D quiz 21-22
- SonierBPatrickCAjjikuttiraPScottFWIntestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunityInt Rev Immunol200928 414 445 https://doi.org/10.3109/08830180903208329 19954357 1:CAS:528:DC%2BD1MXhsFSrur3O 19954357
- JeukendrupAEVet-JoopKSturkAStegenJHSendenJSarisWHWagenmakersAJRelationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained menClin Sci (Lond)200098 47 55 https://doi.org/10.1042/cs0980047 1:STN:280:DC%2BD3c%2FmvFartw%3D%3D
- ReidGProbiotics: definition, scope and mechanisms of actionBest Pract Res Clin Gastroenterol201630 17 25 https://doi.org/10.1016/j.bpg.2015.12.001 27048893 1:CAS:528:DC%2BC2MXitV2ntbnK 27048893
- LangaSMartin-CabrejasIMontielRLandeteJMMedinaMArquesJLShort communication: combined antimicrobial activity of reuterin and diacetyl against foodborne pathogensJ Dairy Sci201497 6116 6121 https://doi.org/10.3168/jds.2014-8306 25087026 1:CAS:528:DC%2BC2cXhsFylur3I 25087026
- VelraedsMMvan de Belt-GritterBvan der MeiHCReidGBusscherHJInterference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactantJ Med Microbiol199847 1081 1085 https://doi.org/10.1099/00222615-47-12-1081 9856644 1:STN:280:DyaK1M%2Fnt1Cltg%3D%3D 9856644
- Bermudez-BritoMPlaza-DiazJMunoz-QuezadaSGomez-LlorenteCGilAProbiotic mechanisms of actionAnn Nutr Metab201261 160 174 https://doi.org/10.1159/000342079 23037511 1:CAS:528:DC%2BC38Xhs1ahsbfN 23037511
- OhlandCLMacnaughtonWKProbiotic bacteria and intestinal epithelial barrier functionAm J Physiol Gastrointest Liver Physiol2010298 G807 G819 https://doi.org/10.1152/ajpgi.00243.2009 20299599 1:CAS:528:DC%2BC3cXnvFamtrs%3D 20299599
- HooperLVStappenbeckTSHongCVGordonJIAngiogenins: a new class of microbicidal proteins involved in innate immunityNat Immunol20034 269 273 https://doi.org/10.1038/ni888 12548285 1:CAS:528:DC%2BD3sXhsVGisLg%3D 12548285
- HooperLVWongMHThelinAHanssonLFalkPGGordonJIMolecular analysis of commensal host-microbial relationships in the intestineScience2001291 881 884 https://doi.org/10.1126/science.291.5505.881 11157169 1:CAS:528:DC%2BD3MXpvVegtg%3D%3D 11157169
- AndersonRCCooksonALMcNabbWCParkZMcCannMJKellyWJRoyNCLactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formationBMC Microbiol201010 316 https://doi.org/10.1186/1471-2180-10-316 21143932 3004893 1:CAS:528:DC%2BC3cXhsF2hs7nI
- MackDRAhrneSHydeLWeiSHollingsworthMAExtracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitroGut200352 827 833 12740338 1773687 https://doi.org/10.1136/gut.52.6.827 1:CAS:528:DC%2BD3sXkvFCiur0%3D
- MattarAFTeitelbaumDHDrongowskiRAYongyiFHarmonCMCoranAGProbiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture modelPediatr Surg Int200218 586 590 https://doi.org/10.1007/s00383-002-0855-7 12471471 1:STN:280:DC%2BD38jgvFGnsA%3D%3D 12471471
- ZuhlMSchneiderSLanphereKConnCDokladnyKMoseleyPExercise regulation of intestinal tight junction proteinsBr J Sports Med201448 980 986 https://doi.org/10.1136/bjsports-2012-091585 23134759 23134759
- FlynnMGMcFarlinBKToll-like receptor 4: link to the anti-inflammatory effects of exercise?Exerc Sport Sci Rev200634 176 181 https://doi.org/10.1249/01.jes.0000240027.22749.14 17031256 17031256
- StuempfleKJValentinoTHew-ButlerTHechtFMHoffmanMDNausea is associated with endotoxemia during a 161-km ultramarathonJ Sports Sci16622016 34 https://doi.org/10.1080/02640414.2015.1130238 1668
- MunfordRSSensing gram-negative bacterial lipopolysaccharides: a human disease determinant?Infect Immun200876 454 465 https://doi.org/10.1128/IAI.00939-07 18086818 1:CAS:528:DC%2BD1cXhsFOqs7g%3D 18086818
- MachNFuster-BotellaDEndurnace exercise and gut microbiota: a reviewJ Sport Health Sci20176 179 197 30356594 https://doi.org/10.1016/j.jshs.2016.05.001 30356594
- LescheidDProbiotics as regulators of inflammation: a reviewFunctional Foods in Health and Disease20144 299 311 https://doi.org/10.31989/ffhd.v4i7.2
- PagniniCSaeedRBamiasGArseneauKOPizarroTTCominelliFProbiotics promote gut health through stimulation of epithelial innate immunityProc Natl Acad Sci U S A2010107 454 459 https://doi.org/10.1073/pnas.0910307107 20018654
- KarczewskiJTroostFJKoningsIDekkerJKleerebezemMBrummerRJWellsJMRegulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrierAm J Physiol Gastrointest Liver Physiol2010298 G851 G859 https://doi.org/10.1152/ajpgi.00327.2009 20224007 1:CAS:528:DC%2BC3cXnvFamtrc%3D
- CarioEGerkenGPodolskyDKToll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier functionGastroenterology2007132 1359 1374 https://doi.org/10.1053/j.gastro.2007.02.056 17408640 1:CAS:528:DC%2BD2sXlslKrurk%3D
- PerdigonGMaldonado GaldeanoCValdezJCMediciMInteraction of lactic acid bacteria with the gut immune systemEur J Clin Nutr200256 Suppl 4 S21 S26 https://doi.org/10.1038/sj.ejcn.1601658 12556943 1:CAS:528:DC%2BD3sXitVCktbo%3D
- SchiffrinEJBrassartDServinALRochatFDonnet-HughesAImmune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selectionAm J Clin Nutr199766 515S 520S https://doi.org/10.1093/ajcn/66.2.515S 9250141 1:CAS:528:DyaK2sXltVejsrw%3D
- HiranoJYoshidaTSugiyamaTKoideNMoriIYokochiTThe effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitroMicrobiol Immunol200347 405 409 12906100 https://doi.org/10.1111/j.1348-0421.2003.tb03377.x 1:CAS:528:DC%2BD3sXlslCqsb0%3D
- KimYSHoSBIntestinal goblet cells and mucins in health and disease: recent insights and progressCurr Gastroenterol Rep201012 319 330 https://doi.org/10.1007/s11894-010-0131-2 20703838 2933006
- AyabeTSatchellDPWilsonCLParksWCSelstedMEOuelletteAJSecretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteriaNat Immunol20001 113 118 https://doi.org/10.1038/77783 11248802 1:CAS:528:DC%2BD3cXlsFOmur4%3D
- OstaffMJStangeEFWehkampJAntimicrobial peptides and gut microbiota in homeostasis and pathologyEMBO Mol Med20135 1465 1483 https://doi.org/10.1002/emmm.201201773 24039130 3799574 1:CAS:528:DC%2BC3sXhsFOgsrjE
- FurrieEMacfarlaneSKennedyACummingsJHWalshSVO'NeilDAMacfarlaneGTSynbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trialGut200554 242 249 https://doi.org/10.1136/gut.2004.044834 15647189 1774839 1:STN:280:DC%2BD2M%2FitFSrsA%3D%3D
- ServinALAntagonistic activities of lactobacilli and bifidobacteria against microbial pathogensFEMS Microbiol Rev200428 405 440 https://doi.org/10.1016/j.femsre.2004.01.003 15374659 1:CAS:528:DC%2BD2cXnslGhsLs%3D 15374659
- ChenollECasinosBBatallerEAstalsPEchevarriaJIglesiasJRBalbariePRamonDGenovesSNovel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium helicobacter pyloriAppl Environ Microbiol201177 1335 1343 https://doi.org/10.1128/AEM.01820-10 21169430 1:CAS:528:DC%2BC3MXhtVeju7vN 21169430
- ChuHKangSHaSChoKParkSMHanKHKangSKLeeHHanSHYunCH et al Lactobacillus acidophilus expressing recombinant K99 adhesive fimbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coliMicrobiol Immunol200549 941 948 16301804 https://doi.org/10.1111/j.1348-0421.2005.tb03687.x 1:CAS:528:DC%2BD2MXhtlektbjI 16301804
- MunozJAChenollECasinosBBatallerERamonDGenovesSMontavaRRibesJMBuesaJFabregaJ et al Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infectionsAppl Environ Microbiol201177 8775 8783 https://doi.org/10.1128/AEM.05548-11 22003027 1:CAS:528:DC%2BC3MXhs1ykt77I 22003027
- SgourasDMaragkoudakisPPetrakiKMartinez-GonzalezBEriotouEMichopoulosSKalantzopoulosGTsakalidouEMentisAIn vitro and in vivo inhibition of helicobacter pylori by Lactobacillus casei strain ShirotaAppl Environ Microbiol200470 518 526 14711683 321236 https://doi.org/10.1128/AEM.70.1.518-526.2004 1:CAS:528:DC%2BD2cXmvFaltg%3D%3D
- TodorikiKMukaiTSatoSTobaTInhibition of adhesion of food-borne pathogens to Caco-2 cells by Lactobacillus strainsJ Appl Microbiol200191 154 159 11442725 https://doi.org/10.1046/j.1365-2672.2001.01371.x 1:STN:280:DC%2BD3MvhsFentg%3D%3D 11442725
- TsaiCCLinPPHsiehYMThree Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitroAnaerobe200814 61 67 https://doi.org/10.1016/j.anaerobe.2007.11.003 18182312 1:CAS:528:DC%2BD1cXlslKlsr0%3D 18182312
- NakamuraSKudaTAnCKannoTTakahashiHKimuraBInhibitory effects of Leuconostoc mesenteroides 1RM3 isolated from narezushi, a fermented fish with rice, on listeria monocytogenes infection to Caco-2 cells and a/J miceAnaerobe201218 19 24 https://doi.org/10.1016/j.anaerobe.2011.11.006 22193553
- SchiffrinEJBlumSInteractions between the microbiota and the intestinal mucosaEur J Clin Nutr200256 Suppl 3 S60 S64 https://doi.org/10.1038/sj.ejcn.1601489 12142966 12142966
- FujiwaraSHashibaHHirotaTForstnerJFInhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surfaceInt J Food Microbiol200167 97 106 11482574 https://doi.org/10.1016/S0168-1605(01)00432-9 1:CAS:528:DC%2BD3MXltVaku78%3D
- NeeserJRGranatoDRouvetMServinATenebergSKarlssonKALactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteriaGlycobiology200010 1193 1199 11087711 https://doi.org/10.1093/glycob/10.11.1193 1:CAS:528:DC%2BD3cXosVOjtbk%3D
- MukaiTAsasakaTSatoEMoriKMatsumotoMOhoriHInhibition of binding of helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteriFEMS Immunol Med Microbiol200232 105 110 11821231 https://doi.org/10.1111/j.1574-695X.2002.tb00541.x 1:CAS:528:DC%2BD38Xos1Gnuw%3D%3D 11821231
- CoconnierMHBernetMFChauviereGServinALAdhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cellsJ Diarrhoeal Dis Res199311 235 242 8188996 1:STN:280:DyaK2c3ks1Wjsw%3D%3D 8188996
- KonstantinovSRKuipersEJPeppelenboschMPFunctional genomic analyses of the gut microbiota for CRC screeningNat Rev Gastroenterol Hepatol201310 741 745 https://doi.org/10.1038/nrgastro.2013.178 24042452 1:CAS:528:DC%2BC3sXhsVymsrrO 24042452
- ObergTSSteeleJLInghamSCSmeianovVVBriczinskiEPAbdallaABroadbentJRIntrinsic and inducible resistance to hydrogen peroxide in Bifidobacterium speciesJ Ind Microbiol Biotechnol19472011 38 https://doi.org/10.1007/s10295-011-0983-y 1:CAS:528:DC%2BC3MXhsFSjtL7P 1953
- TsilingiriKRescignoMPostbiotics: what else?Benefic Microbes20134 101 107 https://doi.org/10.3920/BM2012.0046 1:CAS:528:DC%2BC3sXnsVCltr8%3D
- SharmaMShuklaGMetabiotics: one step ahead of probiotics; an insight into mechanisms involved in Anticancerous effect in colorectal CancerFront Microbiol19402016 7 https://doi.org/10.3389/fmicb.2016.01940
- Shenderov BA. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis. 2013;24. https://doi.org/https://doi.org/10.3402/mehd.v24i0.20399.
- CanforaEEJockenJWBlaakEEShort-chain fatty acids in control of body weight and insulin sensitivityNat Rev Endocrinol201511 577 591 https://doi.org/10.1038/nrendo.2015.128 26260141 1:CAS:528:DC%2BC2MXhtlGgtL3E 26260141
- KimuraIOzawaKInoueDImamuraTKimuraKMaedaTTerasawaKKashiharaDHiranoKTaniT et al The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43Nat Commun18292013 4 https://doi.org/10.1038/ncomms2852 1:CAS:528:DC%2BC3sXhtVejs7bF
- den BestenGvan EunenKGroenAKVenemaKReijngoudDJBakkerBMThe role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolismJ Lipid Res201354 2325 2340 https://doi.org/10.1194/jlr. R036012
- KullisaarTZilmerMMikelsaarMVihalemmTAnnukHKairaneCKilkATwo antioxidative lactobacilli strains as promising probioticsInt J Food Microbiol200272 215 224 11845820 https://doi.org/10.1016/S0168-1605(01)00674-2 1:CAS:528:DC%2BD38XktFSktw%3D%3D 11845820
- LinMYChangFJAntioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356Dig Dis Sci16172000 45 1622
- SaideJAGillilandSEAntioxidative activity of lactobacilli measured by oxygen radical absorbance capacityJ Dairy Sci200588 1352 1357 https://doi.org/10.3168/jds. S0022-0302(05)72801-0 15778302 1:CAS:528:DC%2BD2MXivVyktb8%3D 15778302
- CoqueiroAYde Oliveira GarciaABRogeroMMTirapeguiJProbiotic supplementation in sports and physical exercise: does it present any ergogenic effect?Nutr Health201723 239 249 https://doi.org/10.1177/0260106017721000 29214927 1:CAS:528:DC%2BC1cXhvVCru74%3D 29214927
- AkbariVHendijaniFEffects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysisNutr Rev201674 774 784 https://doi.org/10.1093/nutrit/nuw039 27864537 27864537
- RuanYSunJHeJChenFChenRChenHEffect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, Controlled TrialsPLoS One201510 e0132121 https://doi.org/10.1371/journal.pone.0132121 26161741 4498615 1:CAS:528:DC%2BC2MXhsVSrtbzM
- AlakomiHLSkyttaESaarelaMMattila-SandholmTLatva-KalaKHelanderIMLactic acid permeabilizes gram-negative bacteria by disrupting the outer membraneAppl Environ Microbiol20012000 66 2005
- De KeersmaeckerSCVerhoevenTLDesairJMarchalKVanderleydenJNagyIStrong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acidFEMS Microbiol Lett2006259 89 96 https://doi.org/10.1111/j.1574-6968.2006.00250.x 16684107 1:CAS:528:DC%2BD28Xlt1Cjt7o%3D 16684107
- MakrasLTriantafyllouVFayol-MessaoudiDAdrianyTZoumpopoulouGTsakalidouEServinADe VuystLKinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar typhimurium reveals a role for lactic acid and other inhibitory compoundsRes Microbiol2006157 241 247 https://doi.org/10.1016/j.resmic.2005.09.002 16266797 1:CAS:528:DC%2BD28Xis1Srt7s%3D 16266797
- RussellJBDiez-GonzalezFThe effects of fermentation acids on bacterial growthAdv Microb Physiol199839 205 234 9328648 https://doi.org/10.1016/S0065-2911(08)60017-X 1:CAS:528:DyaK2sXnt1yhs78%3D 9328648
- MacouzetMLeeBHRobertNProduction of conjugated linoleic acid by probiotic Lactobacillus acidophilus La-5J Appl Microbiol18862009 106 https://doi.org/10.1111/j.1365-2672.2009.04164.x 1:CAS:528:DC%2BD1MXnslWiu7Y%3D 1891
- O'SheaEFCotterPDStantonCRossRPHillCProduction of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acidInt J Food Microbiol2012152 189 205 https://doi.org/10.1016/j.ijfoodmicro.2011.05.025 21742394 1:CAS:528:DC%2BC3MXhs1Ght73K 21742394
- LeeKPaekKLeeHYParkJHLeeYAntiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese miceJ Appl Microbiol2007103 1140 1146 https://doi.org/10.1111/j.1365-2672.2007.03336.x 17897219 1:CAS:528:DC%2BD2sXhtlSqu73O 17897219
- NiemanDCHensonDAAustinMDShaWUpper respiratory tract infection is reduced in physically fit and active adultsBr J Sports Med201145 987 992 https://doi.org/10.1136/bjsm.2010.077875 21041243 21041243
- GleesonMBishopNCURI in athletes: are mucosal immunity and cytokine responses key risk factors?Exerc Sport Sci Rev201341 148 153 https://doi.org/10.1097/JES.0b013e3182956ead 23792489 23792489
- WalshNPRecommendations to maintain immune health in athletesEur J Sport Sci201818 820 831 https://doi.org/10.1080/17461391.2018.1449895 29637836 29637836
- WalshNPGleesonMShephardRJGleesonMWoodsJABishopNCFleshnerMGreenCPedersenBKHoffman-GoetzL et al Position statement. Part one: Immune function and exerciseExerc Immunol Rev201117 6 63 21446352 21446352
- Gomez-LlorenteCMunozSGilARole of toll-like receptors in the development of immunotolerance mediated by probioticsProc Nutr Soc201069 381 389 https://doi.org/10.1017/S0029665110001527 20416121 1:CAS:528:DC%2BC3cXovFequ7c%3D 20416121
- LebeerSVanderleydenJDe KeersmaeckerSCHost interactions of probiotic bacterial surface molecules: comparison with commensals and pathogensNat Rev Microbiol20108 171 184 https://doi.org/10.1038/nrmicro2297 20157338 1:CAS:528:DC%2BC3cXhvFOisro%3D 20157338
- BermonSPetrizBKajenieneAPrestesJCastellLFrancoOLThe microbiota: an exercise immunology perspectiveExerc Immunol Rev201521 70 79 25825908 25825908
- LancasterGIHalsonSLKhanQDrysdalePWallaceFJeukendrupAEDraysonMTGleesonMEffects of acute exhaustive exercise and chronic exercise training on type 1 and type 2 T lymphocytesExerc Immunol Rev200410 91 106 15633589 15633589
- MartinSAPenceBDWoodsJAExercise and respiratory tract viral infectionsExerc Sport Sci Rev200937 157 164 https://doi.org/10.1097/JES.0b013e3181b7b57b 19955864 2803113
- JagerRPurpuraMFarmerSCashHAKellerDProbiotic Bacillus coagulans GBI-30, 6086 improves protein absorption and utilizationProbiotics Antimicrob Proteins201810 611 615 https://doi.org/10.1007/s12602-017-9354-y 29196920 1:CAS:528:DC%2BC2sXhvFejsrfF 29196920
- KellerDVan DinterRCashHFarmerSVenemaKBacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1)Benefic Microbes20178 491 496 https://doi.org/10.3920/BM2016.0196 1:CAS:528:DC%2BC1cXitFeqtb%2FP
- BuckleyJDThomsonRLCoatesAMHowePRDeNichiloMORowneyMKSupplementation with a whey protein hydrolysate enhances recovery of muscle force-generating capacity following eccentric exerciseJ Sci Med Sport201013 178 181 https://doi.org/10.1016/j.jsams.2008.06.007 18768358 18768358
- BentonDWilliamsCBrownAImpact of consuming a milk drink containing a probiotic on mood and cognitionEur J Clin Nutr200761 355 361 https://doi.org/10.1038/sj.ejcn.1602546 17151594 1:STN:280:DC%2BD2s7ivVChtg%3D%3D 17151594
- de SimoneClaudioThe Unregulated Probiotic MarketClinical Gastroenterology and Hepatology201917 5 809 817 29378309 https://doi.org/10.1016/j.cgh.2018.01.018 29378309
- World Gastroenterology Organisation. Global Guidelines: Probiotics and Prebiotics. World Gastroentereology Oganisation. Milwaukee; 2017.
- SandersMEAkkermansLMHallerDHammermanCHeimbachJHormannspergerGHuysGLevyDDLutgendorffFMackD et al Safety assessment of probiotics for human useGut Microbes20101 164 185 https://doi.org/10.4161/gmic.1.3.12127 21327023 3023597
- MarteauPSafety aspects of probiotic productsNaringsforskning200145 22 24 https://doi.org/10.3402/fnr.v45i0.1785
- CesaroCTisoADel PreteACarielloRTuccilloCCotticelliGDel Vecchio BlancoCLoguercioCGut microbiota and probiotics in chronic liver diseasesDig Liver Dis201143 431 438 https://doi.org/10.1016/j.dld.2010.10.015 21163715 21163715
- BesselinkMGvan SantvoortHCBuskensEBoermeesterMAvan GoorHTimmermanHMNieuwenhuijsVBBollenTLvan RamshorstBWittemanBJ et al Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trialLancet2008371 651 659 https://doi.org/10.1016/S0140-6736(08)60207-X 18279948 18279948
- SandersMEMerensteinDJOuwehandACReidGSalminenSCabanaMDParaskevakosGLeyerGProbiotic use in at-risk populationsJ Am Pharm Assoc (2003)201656 680 686 https://doi.org/10.1016/j.japh.2016.07.001
- Vallabhaneni S, Walker TA, Lockhart SR, Ng D, Chiller T, Melchreit R, Brandt ME, Smith RM. Centers for Disease Control and Prevention, see https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a6.htm.
- FDA. New Dietary Ingredients Notification Process. Washington; 2016.
- DidariTSolkiSMozaffariSNikfarSAbdollahiMA systematic review of the safety of probioticsExpert Opin Drug Saf201413 227 239 https://doi.org/10.1517/14740338.2014.872627 24405164 24405164
- BoyleRJRobins-BrowneRMTangMLProbiotic use in clinical practice: what are the risks?Am J Clin Nutr200683 1256 1264 https://doi.org/10.1093/ajcn/83.6.1256 16762934 1:CAS:528:DC%2BD28XlvFCmtLo%3D 16762934 quiz 1446-1257
- TapiovaaraLLehtorantaLPoussaTMakivuokkoHKorpelaRPitkarantaAAbsence of adverse events in healthy individuals using probiotics--analysis of six randomised studies by one study groupBenefic Microbes20167 161 169 https://doi.org/10.3920/BM2015.0096 1:STN:280:DC%2BC28rjsVektg%3D%3D
- LarsenCNNielsenSKaestelPBrockmannEBennedsenMChristensenHREskesenDCJacobsenBLMichaelsenKFDose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adultsEur J Clin Nutr200660 1284 1293 https://doi.org/10.1038/sj.ejcn.1602450 16721394 1:CAS:528:DC%2BD28XhtFChs77I 16721394
- FordAlexander CQuigleyEamonn M MLacyBrian ELemboAnthony JSaitoYuri ASchillerLawrence RSofferEdy ESpiegelBrennan M RMoayyediPaulEfficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysisAmerican Journal of Gastroenterology2014109 10 1547 1561 25070051 https://doi.org/10.1038/ajg.2014.202 25070051
- MonteiroRosárioAzevedoIsabelChronic Inflammation in Obesity and the Metabolic SyndromeMediators of Inflammation20102010 1 10 https://doi.org/10.1155/2010/289645 1:CAS:528:DC%2BC3cXptVGksLk%3D
- Food and Agriculture Organization of the United Nations and World Health Organization Joint FAO/WHO working group report on drafting guidelines fro the evaluation of probiotics in food2002
- Health Canada. Natural Health Products Ingredients Database: Probiotics. Availabe online: http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=probio&lang=eng (accessed on Oct 23).
- ZorzelaLArdestaniSKMcFarlandLVVohraSIs there a role for modified probiotics as beneficial microbes: a systematic review of the literatureBenefic Microbes20178 739 754 https://doi.org/10.3920/BM2017.0032 1:STN:280:DC%2BC1cblvFOhtA%3D%3D
- Health Canada. Licensed Natural Health Products Database. 2019. . Availabe online: https://health-products.canada.ca/lnhpd-bdpsnh/index-eng.jsp (accessed on Oct 23).
- AroraMBaldiARegulatory categories of probiotics across the globe: a review representing existing and recommended categorizationIndian J Med Microbiol201533 Suppl 2 10 https://doi.org/10.4103/0255-0857.150868 25657150 25657150
- AmagaseHCurrent marketplace for probiotics: a Japanese perspectiveClin Infect Dis200846 Suppl 2 S73 S75 https://doi.org/10.1086/523338 18181727 18181727 discussion S144–151
- European Food Standards Agency. Qualified Presumption of Safety. Available from: http://www.efsa.europa.eu/en/topics/topic/qualified-presumption-safety-qps. Access date: 10 Aug 2018.
- KolacekSHojsakIBerni CananiRGuarinoAIndrioFOrelRPotBShamirRSzajewskaHVandenplasY et al Commercial probiotic products: a call for improved quality control. A position paper by the ESPGHAN working Group for Probiotics and PrebioticsJ Pediatr Gastroenterol Nutr201765 117 124 https://doi.org/10.1097/MPG.0000000000001603 28644359 28644359
- NIH. Probiotics: In Depth. https://nccih.nih.gov/health/probiotics/introduction.htm. 2016.
- Giordano-Schaefer, J.; Ruthsatz, M.; Schneider, H. Overcoming distinctive regulatory barriers for the development of medical foods. Availabe online: https://www.raps.org/regulatory-focus%E2%84%A2/news-articles/2017/10/overcoming-distinctive-regulatory-barriers-for-the-development-of-medical-foods (Accessed on Oct 2017).
- KullenMJAmannMMO'ShaughnessyMJO'SullivanDJBustaFFBradyLJDifferentiation of ingested and endogenous bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humansJ Nutr1997127 89 94 https://doi.org/10.1093/jn/127.1.89 9040550 1:CAS:528:DyaK2sXhtFKrtr8%3D 9040550
- PoutahidisTSpringerALevkovichTQiPVarianBJLakritzJRIbrahimYMChatzigiagkosAAlmEJErdmanSEProbiotic microbes sustain youthful serum testosterone levels and testicular size in aging micePLoS One20149 e84877 https://doi.org/10.1371/journal.pone.0084877 24392159 3879365 1:CAS:528:DC%2BC2cXltlOitLo%3D
- LyteMProbiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probioticsBioessays201133 574 581 https://doi.org/10.1002/bies.201100024 21732396 1:CAS:528:DC%2BC3MXovF2is7g%3D 21732396
- BravoJAForsythePChewMVEscaravageESavignacHMDinanTGBienenstockJCryanJFIngestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerveProc Natl Acad Sci U S A2011108 16050 16055 https://doi.org/10.1073/pnas.1102999108 21876150 3179073
- SteenbergenLSellaroRvan HemertSBoschJAColzatoLSA randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad moodBrain Behav Immun201548 258 264 https://doi.org/10.1016/j.bbi.2015.04.003 25862297 25862297
- KimJYunJMKimMKKwonOChoBLactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, Placebo-Controlled TrialJ Med Food201821 454 461 https://doi.org/10.1089/jmf.2017.3937 29688793 1:CAS:528:DC%2BC1cXps1Klsbk%3D 29688793
- SanchezMDarimontCDrapeauVEmady-AzarSLepageMRezzonicoENgom-BruCBergerBPhilippeLAmmon-ZuffreyC et al Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and womenBr J Nutr2014111 1507 1519 https://doi.org/10.1017/S0007114513003875 24299712 1:CAS:528:DC%2BC2cXkslSmtb0%3D 24299712
- GauchardGCGangloffPVouriotAMallieJPPerrinPPEffects of exercise-induced fatigue with and without hydration on static postural control in adult human subjectsInt J Neurosci2002112 1191 1206 12587522 https://doi.org/10.1080/00207450290026157 12587522
- GreenHHalestrapAMockettCO'TooleDGrantSOuyangJIncreases in muscle MCT are associated with reductions in muscle lactate after a single exercise session in humansAm J Physiol Endocrinol Metab2002282 E154 E160 https://doi.org/10.1152/ajpendo.2002.282.1.E154 11739096 1:CAS:528:DC%2BD38XlsVKktQ%3D%3D 11739096
- HobsonRMSaundersBBallGHarrisRCSaleCEffects of beta-alanine supplementation on exercise performance: a meta-analysisAmino Acids201243 25 37 https://doi.org/10.1007/s00726-011-1200-z 22270875 3374095 1:CAS:528:DC%2BC38XotlOhtrY%3D
- BrooksSPStoreyKBA quantitative evaluation of the effect of enzyme complexes on the glycolytic rate in vivo: mathematical modeling of the glycolytic complexJ Theor Biol1991149 361 375 2062101 https://doi.org/10.1016/S0022-5193(05)80311-X 1:CAS:528:DyaK38XhslOrtw%3D%3D 2062101
- DuncanSHLouisPFlintHJLactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation productAppl Environ Microbiol200470 5810 5817 https://doi.org/10.1128/AEM.70.10.5810-5817.2004 522113 522113 1:CAS:528:DC%2BD2cXosl2itb8%3D
- HsuYi-JuHuangWen-ChingLinJin-SengChenYi-MingHoShang-TseHuangChi-ChangTungYu-TangKefir Supplementation Modifies Gut Microbiota Composition, Reduces Physical Fatigue, and Improves Exercise Performance in MiceNutrients201810 7 862 6073576 https://doi.org/10.3390/nu10070862 1:CAS:528:DC%2BC1cXisFKmu7nK
- ANVISA-Ministry of Health Technical Regulation of Bioeactive and Probiotic Substances Isolated with Allegations of Functional or Health Properties2008
- Ministerio della Salute Linee guida su probiotici e prebioticic2013 Available oneline at: http://www.salute.gov
- Al-AsmakhMStukenborgJBRedaAAnuarFStrandMLHedinLPetterssonSSoderOThe gut microbiota and developmental programming of the testis in micePLoS One20149 e103809 https://doi.org/10.1371/journal.pone.0103809 25118984 4132106 1:CAS:528:DC%2BC2cXhs1Cjt7fO
- HaradaNHanaokaRHoriuchiHKitakazeTMitaniTInuiHYamajiRCastration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed miceSci Rep20166 23001 https://doi.org/10.1038/srep23001 26961573 4785334 1:CAS:528:DC%2BC28XktVamur4%3D
- IbrahimHAZhuYWuCLuCEzekweMOLiaoSFHuangKSelenium-enriched probiotics improves murine male fertility compromised by high fat dietBiol Trace Elem Res2012147 251 260 https://doi.org/10.1007/s12011-011-9308-2 22207218 1:CAS:528:DC%2BC38Xnslals7Y%3D 22207218
- LeeJYangWHostetlerASchultzNSuckowMAStewartKLKimDDKimHSCharacterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged miceBMC Microbiol201616 69 https://doi.org/10.1186/s12866-016-0686-7 27095067 4837529 1:CAS:528:DC%2BC2sXnsFKitL4%3D
- McMullenMHHamilton-ReevesJMBonordenMJWangenKEPhippsWRFeirtagJMKurzerMSConsumption of Lactobacillus acidophilus and Bifidobacterium longum does not alter phytoestrogen metabolism and plasma hormones in men: a pilot studyJ Altern Complement Med200612 887 894 https://doi.org/10.1089/acm.2006.12.887 17109580 17109580
- MarettiCCavalliniGThe association of a probiotic with a prebiotic (Flortec, Bracco) to improve the quality/quantity of spermatozoa in infertile patients with idiopathic oligoasthenoteratospermia: a pilot studyAndrology20175 439 444 https://doi.org/10.1111/andr.12336 28245352 1:CAS:528:DC%2BC2sXlvF2rs7s%3D 28245352
- TremellenKGut endotoxin leading to a decline IN gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese menBasic Clin Androl201626 7 https://doi.org/10.1186/s12610-016-0034-7 27340554 4918028
- TremellenKMcPheeNPearceKMetabolic endotoxaemia related inflammation is associated with hypogonadism in overweight menBasic Clin Androl201727 5 https://doi.org/10.1186/s12610-017-0049-8 28286655 5341351
- TremellenKMcPheeNPearceKBensonSSchedlowskiMEnglerHEndotoxin-initiated inflammation reduces testosterone production in men of reproductive ageAm J Physiol Endocrinol Metab2018314 E206 E213 https://doi.org/10.1152/ajpendo.00279.2017 29183872 1:CAS:528:DC%2BC1cXhslCku7fP 29183872
- De LorenzoAntoninoNoceAnnalisaMoriconiEleonoraRampelloTizianaMarroneGiuliaDi DanieleNicolaRovellaValentinaMOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic ApproachesNutrients201810 4 474 5946259 https://doi.org/10.3390/nu10040474 1:CAS:528:DC%2BC1cXitlOjtLbM
- PiquéNúriaBerlangaMercedesMiñana-GalbisDavidHealth Benefits of Heat-Killed (Tyndallized) Probiotics: An OverviewInternational Journal of Molecular Sciences201920 10 2534 6566317 https://doi.org/10.3390/ijms20102534
- KomanoYShimadaKNaitoHFukaoKIshiharaYFujiiTKokuboTDaidaHEfficacy of heat-killed Lactococcus lactis JCM 5805 on immunity and fatigue during consecutive high intensity exercise in male athletes: a randomized, placebo-controlled, double-blinded trialJ Int Soc Sports Nutr201815 39 https://doi.org/10.1186/s12970-018-0244-9 30071871 6090876 1:CAS:528:DC%2BC1MXjt1Kqu7k%3D
- Kalman D, Hewlings S. Inactivated probiotic Bacillus coagulans GBI-30 demonstrates Immunosupportive properties in healthy adults following stressful exercise. J Probiotics and Health. 2018;6.
- TavernitiVGuglielmettiSThe immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Genes Nutr20116 261 274 https://doi.org/10.1007/s12263-011-0218-x 21499799 3145061 1:CAS:528:DC%2BC2sXhvVahsLfL
- DeshpandeGirishAthalye-JapeGayatriPatoleSanjayPara-probiotics for Preterm Neonates—The Next FrontierNutrients201810 7 871 6073938 https://doi.org/10.3390/nu10070871 1:CAS:528:DC%2BC1cXisFKls7rK
- SugaharaHYaoROdamakiTXiaoJZDifferences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environmentBenefic Microbes20178 463 472 https://doi.org/10.3920/BM2016.0158 1:CAS:528:DC%2BC1cXitFeqtb%2FI
- BurtaOvidiuIacobescuClaudiaMateescuRadu BogdanNicolaieTudorTiucaNicoletaPopCorina SilviaEfficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical studyTranslational Gastroenterology and Hepatology20183 72 72 30511026 6256934 https://doi.org/10.21037/tgh.2018.09.11
- VandenplasYBacareaAMarusteriMBacareaVConstantinMManolacheMEfficacy and safety of APT198K for the treatment of infantile colic: a pilot studyJ Comp Eff Res20176 137 144 https://doi.org/10.2217/cer-2016-0059 28114795 28114795
- HiroseYYamamotoYYoshikaiYMurosakiSOral intake of heat-killed Lactobacillus plantarum L-137 decreases the incidence of upper respiratory tract infection in healthy subjects with high levels of psychological stressJ Nutr Sci20132 e39 https://doi.org/10.1017/jns.2013.35 25191589 4153334 1:CAS:528:DC%2BC2cXovFSksro%3D
- ArimoriYojiroNakamuraRisaHiroseYoshitakaMurosakiShinjiYamamotoYoshihiroShidaraOsamuIchikawaHiroshiYoshikaiYasunobuDaily intake of heat-killedLactobacillus plantarumL-137 enhances type I interferon production in healthy humans and pigsImmunopharmacology and Immunotoxicology201234 6 937 943 22468623 https://doi.org/10.3109/08923973.2012.672425 1:CAS:528:DC%2BC38XhsFOnur%2FI 22468623
- SawadaDaisukeKuwanoYukiTanakaHirokiHaraSusumuUchiyamaYoshihideSugawaraTomonoriFujiwaraShigeruRokutanKazuhitoNishidaKenseiDaily intake of Lactobacillus gasseri CP2305 relieves fatigue and stress-related symptoms in male university Ekiden runners: A double-blind, randomized, and placebo-controlled clinical trialJournal of Functional Foods201957 465 476 https://doi.org/10.1016/j.jff.2019.04.022 1:CAS:528:DC%2BC1MXot1eqtb8%3D
- NishidaKSawadabDKuwanoaYTanakaaHSugawarabTAokibYFujiwarabSRokutanaKDaily administration of paraprobiotic Lactobacillus gasseri CP2305 ameliorates chronic stress-associated symptoms in Japanese medical studentsJ Funct Foods201736 112 121 https://doi.org/10.1016/j.jff.2017.06.031
- FriedrichMJDepression is the leading cause of disability around the worldJAMA2017317 1517 https://doi.org/10.1001/jama.2017.3826 28418491 28418491
- MaesMKuberaMLeunisJCBerkMGeffardMBosmansEIn depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopesActa Psychiatr Scand2013127 344 354 https://doi.org/10.1111/j.1600-0447.2012.01908.x 22900942 1:CAS:528:DC%2BC3sXovVSjtL8%3D
- ClarkeGGrenhamSScullyPFitzgeraldPMoloneyRDShanahanFDinanTGCryanJFThe microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent mannerMol Psychiatry201318 666 673 https://doi.org/10.1038/mp.2012.77 22688187 1:CAS:528:DC%2BC3sXot1aku7w%3D
- VitettaLBamblingMAlfordHThe gastrointestinal tract microbiome, probiotics, and moodInflammopharmacology201422 333 339 https://doi.org/10.1007/s10787-014-0216-x 25266952 1:CAS:528:DC%2BC2cXhs12nsbvK
- RaoAVBestedACBeaulneTMKatzmanMAIorioCBerardiJMLoganACA randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndromeGut Pathog20091 6 https://doi.org/10.1186/1757-4749-1-6 19338686 2664325
- MessaoudiMLalondeRViolleNJavelotHDesorDNejdiABissonJFRougeotCPichelinMCazaubielM et al Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjectsBr J Nutr2011105 755 764 https://doi.org/10.1017/S0007114510004319 20974015 1:CAS:528:DC%2BC3MXitVOjsbo%3D
- MarottaASarnoEDel CasaleAPaneMMognaLAmorusoAFelisGEFiorioMEffects of probiotics on cognitive reactivity, mood, and sleep qualityFront Psychiatry201910 164 https://doi.org/10.3389/fpsyt.2019.00164 30971965 6445894
- ClarkAMachNExercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletesJ Int Soc Sports Nutr201613 43 https://doi.org/10.1186/s12970-016-0155-6 27924137 5121944 1:CAS:528:DC%2BC1cXhsVyltro%3D
- ZhaoSLiuWWangJShiJSunYWangWNingGLiuRHongJAkkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed miceJ Mol Endocrinol201758 1 14 https://doi.org/10.1530/JME-16-0054 27821438
- WarberJPPattonJFTharionWJZeiselSHMelloRPKemnitzCPLiebermanHRThe effects of choline supplementation on physical performanceInt J Sport Nutr Exerc Metab200010 170 181 10861337 https://doi.org/10.1123/ijsnem.10.2.170 1:CAS:528:DC%2BD3cXltlOjsbg%3D
- MartinFPWangYSprengerNHolmesELindonJCKochharSNicholsonJKEffects of probiotic Lactobacillus paracasei treatment on the host gut tissue metabolic profiles probed via magic-angle-spinning NMR spectroscopyJ Proteome Res20076 1471 1481 https://doi.org/10.1021/pr060596a 17316039 1:CAS:528:DC%2BD2sXhvF2qsbY%3D
- WangZKlipfellEBennettBJKoethRLevisonBSDugarBFeldsteinAEBrittEBFuXChungYM et al Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature2011472 57 63 https://doi.org/10.1038/nature09922 21475195 3086762 1:CAS:528:DC%2BC3MXksVCrsrw%3D
- BoutagyNENeilsonAPOsterbergKLSmithsonATEnglundTRDavyBMHulverMWDavyKPProbiotic supplementation and trimethylamine-N-oxide production following a high-fat dietObesity (Silver Spring)201523 2357 2363 https://doi.org/10.1002/oby.21212 1:CAS:528:DC%2BC2MXhvFert7rE
- Borges NA, Stenvinkel P, Bergman P, Qureshi AR, Lindholm B, Moraes C, Stockler-Pinto MB, Mafra D. Effects of probiotic supplementation on trimethylamine-N-oxide plasma levels in hemodialysis patients: a pilot study. Probiotics Antimicrob Proteins. 2018. https://doi.org/https://doi.org/10.1007/s12602-018-9411-1, https://doi.org/https://doi.org/10.1007/s12602-018-9411-1.
- TompkinsTAMainvilleIArcandYThe impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tractBenefic Microbes20112 295 303 https://doi.org/10.3920/BM2011.0022 1:STN:280:DC%2BC38%2FlsVKqtg%3D%3D
- HeCSTsaiMLKoMHChangCKFangSHRelationships among salivary immunoglobulin a, lactoferrin and cortisol in basketball players during a basketball seasonEur J Appl Physiol2010110 989 995 https://doi.org/10.1007/s00421-010-1574-8 20668874 1:CAS:528:DC%2BC3cXhs1aisrzO 20668874
- LiTLLinHCKoMHChangCKFangSHEffects of prolonged intensive training on the resting levels of salivary immunoglobulin a and cortisol in adolescent volleyball playersJ Sports Med Phys Fitness201252 569 573 22976746 1:STN:280:DC%2BC38bmvVCksg%3D%3D 22976746
- TsaiMLLiTLChouLWChangCKHuangSYFangSHResting salivary levels of IgA and cortisol are significantly affected during intensive resistance training periods in elite male weightliftersJ Strength Cond Res201226 2202 2208 https://doi.org/10.1519/JSC.0b013e31823a4246 21997453 21997453
- Ait-BelgnaouiADurandHCartierCChaumazGEutameneHFerrierLHoudeauEFioramontiJBuenoLTheodorouVPrevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in ratsPsychoneuroendocrinology201237 1885 1895 https://doi.org/10.1016/j.psyneuen.2012.03.024 22541937 1:CAS:528:DC%2BC38XhtlOjtL3E 22541937
- KnowlesSRNelsonEAPalomboEAInvestigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illnessBiol Psychol200877 132 137 https://doi.org/10.1016/j.biopsycho.2007.09.010 18023961 18023961
- AnderssonHTullbergCAhrneSHambergKLazou AhrenIMolinGSonessonMHakanssonAOral Administration of Lactobacillus plantarum 299v reduces cortisol levels in human saliva during examination induced stress: a randomized, Double-Blind Controlled TrialInt J Microbiol20162016 8469018 https://doi.org/10.1155/2016/8469018 28101105 5217173 1:CAS:528:DC%2BC1cXht12rsLrI
- Kato-KataokaANishidaKTakadaMKawaiMKikuchi-HayakawaHSudaKIshikawaHGondoYShimizuKMatsukiT et al Fermented Milk containing Lactobacillus casei strain Shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stressAppl Environ Microbiol201682 3649 3658 https://doi.org/10.1128/AEM.04134-15 27208120 4959178 1:CAS:528:DC%2BC28XhvVykur3P
- TakadaMNishidaKKataoka-KatoAGondoYIshikawaHSudaKKawaiMHoshiRWatanabeOIgarashiT et al Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal modelsNeurogastroenterol Motil201628 1027 1036 https://doi.org/10.1111/nmo.12804 26896291 1:CAS:528:DC%2BC28XhtVCisr3K
- KellyJRAllenAPTemkoAHutchWKennedyPJFaridNMurphyEBoylanGBienenstockJCryanJF et al Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjectsBrain Behav Immun201761 50 59 https://doi.org/10.1016/j.bbi.2016.11.018 27865949 1:CAS:528:DC%2BC28XhvFKntr3N 27865949
- ReisDJIlardiSSPuntSEWThe anxiolytic effect of probiotics: a systematic review and meta-analysis of the clinical and preclinical literaturePLoS One201813 e0199041 https://doi.org/10.1371/journal.pone.0199041 29924822 6010276 1:CAS:528:DC%2BC1cXit1GnurjF
- DesbrowBMcCormackJBurkeLMCoxGRFallonKHislopMLoganRMarinoNSawyerSMShawG et al Sports dietitians Australia position statement: sports nutrition for the adolescent athleteInt J Sport Nutr Exerc Metab201424 570 584 https://doi.org/10.1123/ijsnem.2014-0031 24668620 1:CAS:528:DC%2BC1cXmsFCqtr4%3D 24668620
- ShawMTLeggatPAChatterjeeSTravelling to India for the Delhi XIX commonwealth games 2010Travel Med Infect Dis20108 129 138 https://doi.org/10.1016/j.tmaid.2010.04.007 20541132 20541132